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A bioinformatics characterization of secondary metabolism and alkyl citric acid pathway 
reconstruction in Aspergillus niger NRRL3 
Sylwester Palys 
Secondary metabolites (SMs) from fungi have become an integral part of various scientific and 
medical fields as well as providing economic benefits.  The genes involved in the biosynthesis of 
fungal and bacterial SMs are often co-localized in closely linked clusters that are generally 
dormant under laboratory conditions.  Genomics technologies are being intensively used to 
identify SM gene clusters, and suggest methods to promote their expression.  These efforts have 
already been used to discover new natural products, reveal the biosynthetic underpinnings of 
known products, and establish methods to eliminate toxic substances from industrially relevant 
organisms.  An important aspect of SM gene cluster characterization is the development of 
methods to overproduce known compounds which are difficult to synthesize in the lab.  This 
thesis presents the annotation of SM gene clusters in the sequenced genome of Aspergillus niger 
NRRL3.   Using our cluster data as a guide to induce production of secondary metabolites 
through the overproduction of clustered transcription factors, we confirm the identity of the 
regulators that are involved in the biosynthesis of the fumonisins, TAN-1612/BMS-192548, and 
the azanigerones which were also used as positive controls.  Additionally, we discovered three 
previously uncharacterized regulators of compounds whose masses correspond to the 
malformins, pyrophen, and the alkyl citric acids hexylitaconic acid, 2-carboxymethyl-3-
hexylmaleic acid and the tensyuic acids.   Selecting the alkyl citric acids for further investigation, 
we obtained a transcriptomic profile to define the genes of the alkyl citric acid gene cluster in A. 
niger.  Using the identified compounds from mass spectrometry and NMR as well as the 
functional annotations of our defined cluster, I reconstruct a biosynthetic pathway for the alkyl 
citrates I identified.  I then tested the robustness of my reconstruction by successfully predicting 
the accumulation of two early precursors, 2-hexylcitric acid (log2 fold change = 2.982 ± 0.15, p-
value < 0.01) and its anhydride (log2 fold change = 3.792 ± 0.26, p-value < 0.01), as well as the 
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1.1 Secondary metabolism; an overview 
 
Secondary metabolism is the energy expenditure of a cell for metabolic processes not 
required for survival of the organism [1].  Bacteria, fungi and plants produce wide varieties of 
secondary metabolites (SMs) and any single species may possess the ability to produce many 
SMs from different SM classes.  These classes include fatty acids, polyketides, small peptides, 
terpenes, sugars, and alkaloids [2-4].   
With respect to the cellular functions of these molecules, a relatively small number of SM 
compounds have a known role.  In some cases, organisms use SMs as defense mechanisms or as 
offensive measures against other organisms competing for space and other resources.  Other 
cases see SMs used as signalling molecules between organisms.  In addition to the advantages 
provided to the producing organisms, SMs have been exploited for a multitude of uses in human 
society [5].  This is particularly true in the pharmaceutical industry which has seen a renewed 
interest in biosynthesized compounds from secondary metabolism [6] 
1.2 The impact of secondary metabolites on human society 
 
The biological properties of some of the discovered SMs from fungi, plants and bacteria, 
sometimes referred to as natural products, have been indispensable in medicine.  These include 
pharmaceuticals like the antibiotics penicillin and vancomycin, anti-cancer drugs like 
griseofluvin and cholesterol lowering agents like lovastatin [7-10].  Secondary metabolism is 
also used by industry for the production of food additives like caffeine from plants and citric acid 
and gluconic acid from fungi [11-13].   However, not all SMs are created equal; some SMs have 
toxic properties which can cause neural, liver and kidney tissue damage as well as death in 
animals [14, 15]. An overview of some of the well-known SMs including toxins is shown in 
Figure 1.  The useful but also hazardous properties of SMs have helped prompt research into this 




Figure 1. Examples of SMs from a variety of classes produced in bacteria (tetracycline), fungi 
(penicillin, gliotoxin, aflatoxin, kojic acid) and plants (caffeine, nicotine, limonene, eucalyptol, 
jasmonic acid) [16-22].   
 
1.3 General organization of secondary metabolite genes 
 
The genes involved in the production of SMs in bacteria and fungi are often co-localized 
in clusters.   Each gene cluster can produce several related compounds [23].  In plants, these 
genes typically do not cluster; however, recent research shows that in some plant species 
clustering of SM genes does occur [24].   The clustered genes themselves can be highly varied 
but contain some important commonalities.  Clusters usually encode a “backbone” enzyme that 
assembles the core molecular structure of a SM, “tailoring enzymes” which modify the core 
molecule(s) to their final product(s) and in some cases, regulatory and transporter genes 
facilitating cluster activation and metabolite extracellular transport respectively [25, 26] (Figure 




Figure 2. General structure of a SM gene cluster and the mechanism of SM production.  (1) 
Outside stimulus induces production of a clustered transcription factor or some transacting 
regulator.  (2) Transcription and translation of all cluster constituents.  (3) Backbone enzyme 
begins by generating the backbone molecule.  (4) Backbone molecule is modified by tailoring 
enzyme to generate the final products. (5) Metabolite may be exported by a clustered transporter. 
 
Backbone enzymes in secondary metabolism can be subdivided into multiple classes 
defining the SM type that will be generated.  These include the polyketide synthases (PKS) 
making polyketides, non-ribosomal peptide synthetases (NRPS) making short peptides, hybrid 
PKS-NRPS (HPN) combining polyketides and peptides, tryptophan dimethylallyl transferases 
(DMAT) making alkaloids, sesquiterpene cyclases cyclizing terpenes, and fatty acid synthases 
(FAS) making fatty acids [27-30].   
Tailoring enzymes are separate from backbone enzymes but their encoding genes often 
co-localize in the same cluster.  These enzymes carry out chemical reactions which add to the 
diversity of SMs.  Examples include the linking of methyl groups to alcohol groups by o-
methyltransferases and the relocation of carbon-carbon double bonds by isomerases [31, 32].   
While there are many tailoring enzymes on offer, many SM clusters despite producing distinct 
compound products will contain common enzyme types.  Enzymes like P450 monooxygenases 
and methyltransferases are present in numerous clusters that produce diverse classes of SMs 
(Table 1).  Moreover, as previously mentioned, a transporter and/or transcription factor (TF) 
gene is present in the gene cluster which facilitates SM cellular export and cluster expression 
respectively [33].   
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Table 1.  Common tailoring enzymes observed in PKS, NRPS and HPN clusters which have 















Acetylaranotin [34] 0 1 0 0 0 1 
Aflatoxin [35] 2 2 4 0 1 2 
Apicidin [36] 1 1 2 0 0 1 
Aspyridone [37] 1 1 2 1 0 0 
Compactin [38] 1 1 1 0 0 0 
Cercosporin [39] 3 1 0 3 1 1 
Cyclopiazonic acid [40] 1 1 1 0 0 1 
Cytochalasin E [41] 1 0 0 0 0 0 
Equisetin [42] 0 1 1 0 0 1 
Echinocandin B [43] 1 3 1 0 0 0 
Hexadehydro-asterchome [44] 2 1 1 1 0 1 
Pneumocandin B0 [45] 1 1 2 0 0 1 
Pseurotin A [46] 0 0 1 0 0 1 
Pyranonigrin E [47] 1 0 0 1 1 1 
 
1
FAS alpha subunits not shown but are present in aflatoxin and apicidin clusters. Production of 
Gluconic Acid by Some Local Fungi. 
 
1.4 The backbone enzymes 
1.4.1 PKS structural organization 
 
Most PKS enzymes are multi-domain proteins or protein complexes.  To be considered a 
canonical PKS, the enzyme must contain a minimal set of domains. The minimal set includes the 
keto-synthase domain (KS), the acyl-transferase domain (AT) and the acyl-carrier protein 
domain (ACP) [48].   In addition to this minimal set, reducing or optional domains may be 
present.  These help generate diversity in polyketide core molecules through different 
combinations of ketone, alcohol and alkene bond reduction but are not required to produce a 
polyketide [49].  The reducing domains include the dehydratase domain (DH), the keto-reductase 
domain (KR), and the enoyl reductase domain (ER).  In some cases, methyltransferase (MT) 
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domains (adding methyl groups) and thioesterase domains (performing terminal cyclization and 
polyketide-enzyme release reactions) may also be present [50] (Figure 3).   
 
Figure 3. General structure of a PKS backbone enzyme.  The ketone, alcohol and alkene bond 
reduction reactions are depicted.  Blue and red squares represent minimal and reducing/optional 
domains respectively.  Modified from Kehr, J.C., et al [51]. 
 
There are three generally recognized types of PKS enzymes.  These are designated type I 
(further broken down into iterative and modular), type II and type III [52, 53].  Modular type I 
PKSs are multi-protein production lines with each protein or module containing various 
combinations of minimal and reducing PKS domains.  Each module is typically used only once 
during the elongation process to form the complete backbone molecule. Type I modular PKSs 
are the common form found in bacterial species.   
Type I iterative PKS enzymes are single unit large proteins containing all minimal 
domains and sometimes reducing domains.  Each domain can be used multiple times in an 
iterative elongation process creating a growing polyketide chain [53].  Following each elongation 
iteration adding two carbons from a malonyl-CoA extender unit, the reducing domains reduce 
ketone groups in the polyketide to alcohols, to double bonds or finally to single bonds [54].  The 
iterative type I PKSs can be further subdivided into subclasses based on which reducing domains 
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are present.  The PKSs containing just the minimal set of domains (KS, AT and ACP) and 
sometimes a TE or MT domain are considered non-reducing.  The non-reducing type I iterative 
PKSs can also contain starter unit acyl transferase (SAT) and product template (PT) domains.  
The SAT domain allows a non-reducing PKS to use different starting compounds in the first 
iteration of polyketide production while the PT domain facilitates polyketide cyclization [55].  
Structures resulting from the cyclization reactions of PT domains may to some extent predicted 
by the size of the catalytic pocket within the domain [55]. Type I iterative PKSs that have 
reducing domains make up the other three subclasses.  A PKS is highly reducing when all 
reducing domains (DH, KR and ER) are present, partially reducing when some reducing domains 
are present (KR and/or DH) [50] or a 6-methylsalicylic acid synthase PKS when a DH and KR 
domain is present but not MT or TE domains [56, 57].  
These different classes of type I iterative PKS enzymes will produce polyketides with 
differing structures and functional groups. The highly reducing PKS enzymes generally produce 
backbone compounds where most or all keto groups are fully reduced to alkane single bonds 
[58].  For partially reducing PKSs, the backbone compounds are partially reduced polyketides 
containing alcohol groups and alkene carbon-carbon bonds [59]. Non-reducing PKSs produces 
backbone compounds that are “true” polyketides containing only keto groups on the hydrocarbon 
chain.  Additional downstream modifications also tend to produce aromatic/cyclic configurations 
of these polyketides.  Lastly, the 6-methylsalicylic acid synthase PKS produces only 6-
methylsalicylic acid, a small tetraketide used in multiple SM pathways [56, 59].   
The type II and type III PKSs are all single domain proteins and like their multi-domain 
counterparts can in some cases reuse those domains iteratively to produce polyketides [52, 60].  
In type II PKSs all minimal and reducing domains may be present, but these exist as protein 
complexes where each domain is contained in a separate protein.  With the type III PKSs, 
sometimes referred to as chalcone synthases, only a single protein is produced which contains a 
KS domain.  These KS domain proteins exist as a homodimer of two identical KS domain 
containing proteins.  Overall, in filamentous fungi PKS enzymes are generally of the type I 
iterative form.  In some species of fungi the type III PKS may also be present but these enzymes 
are more commonly found in plants.  In the case of the type II PKSs, these can be found in 
bacterial species [53, 61].   
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1.4.1.1 General PKS assembly of polyketides (PK) in fungi 
 
The process of assembly of the polyketide begins by activation of the ACP domain in a 
PKS by a phosphopantetheinyl transferase (PPTase) enzyme transferring a phosphopantetheinyl 
arm to a conserved serine residue.  An acyl starter unit, usually an acetyl-CoA, is loaded onto a 
conserved cysteine residue of the AT domain which then transfers the unit to the KS domain 
aided by the ACP.  Next, the AT domain catalyzes the loading and subsequent transfer of a 
malonyl-CoA extender unit to the phosphopantetheinyl arm of the ACP domain.  Other extender 
units may also be used like the methylmalonyl-CoA [62].  The KS domain then carries out a 
Claisen condensation reaction losing CO2 to form a diketide with its loaded starter and the 
extender unit on the ACP domain.  In highly reducing PKSs and partially PKSs the polyketide is 
reduced by the actions of DH, KR and/or ER domains (Figure 3).  In some PKSs, MT domains 
can also add methyl groups to the growing polyketide.  The polyketide is then transferred back to 
the KS domain and the process continues with another extender unit until a specific length is 
reached.  In some cases, chain length is determined by a chain length factor (CLF) subunit of the 
KS domain.  At the end of the last iteration, the polyketide releases spontaneously or via a TE 
domain if present.  In many non-reducing PKSs the SAT domain selects a starter unit other than 
acetyl-CoA.  For example, a 6-carbon (C6) fatty acid is used to initiate aflatoxin biosynthesis.  
Unlike most bacterial PKSs, in fungi the iterative PKS can use both the minimal and reducing 
domains multiple times.  The sequence of reducing domains can also be varied.  For instance, in 
the first iteration the keto group may be fully reduced to an alkane but in the next iteration the 
keto group may only be reduced to an alcohol or not reduced at all. While much is known about 
the iterative process of polyketide assembly in fungi, prediction of the number of iterations to 
deduce chain length remains elusive.  Only general statements can be made concerning the 
reduction state of the backbone molecule [17, 63-65].  A general mechanism of backbone 




Figure 4.  Schematic of polyketide assembly.  The SAT and PT domains are omitted but the 
action of the SAT domain in non-reducing PKSs occurs in step 1 loading a non-acetyl-CoA 
starter unit.  The point at which the PT domain acts is currently unclear.   Modified from Rasmus 





1.4.2 NRPS structural organization 
 
Non-ribosomal peptide synthetases in fungi produce amino acid based SMs in an 
assembly line fashion without the use of a ribosome.  The NRPS selects amino acids and 
incorporates them into a growing peptide chain.  These enzymes comprise multiple fused 
modules, each composed of several domains (Figure 5). Unlike ribosomal peptide synthesis, 
which can also produce SM peptides [66], NRPSs do not require RNA template for biosynthesis 
and can also incorporate non-proteinogenic amino acids into the peptide chain such as D-amino 
acids.  Three types of NRPS systems have been defined: The linear form where all domains are 
used once during assembly, the iterative form where sites can be reused cyclically during 
assembly, and the non-linear form where some modules and/or domains in the same NPRS can 
be reused [50]. 
 
 
Figure 5. General structure of an NRPS backbone enzyme.  Amino acid adenylation is 
depicted.  Blue and red circles represent minimal and reducing domains respectively.  Modified 
from Kehr, J.C., et al [51]. 
 
Like in the PKS backbone enzymes, NRPSs have minimal domains.  There are three 




thiolation domain (PCP or T domain), and a condensation domain (C domain).  Each A domain 
selects a single amino acid and then activates it by adenylation from ATP hydrolysis. The T 
domain acts as a placeholder for the peptide chain and is similar in function to the ACP domain 
in PKSs.  Lastly, the C domain carries out the peptide bond reaction joining amino acids to the 
growing peptide [67].   
The NRPS enzymes like PKS enzymes can be further broken down into linear, iterative 
and non-linear NRPS forms.  Unlike the PKS enzymes the subclass distinctions of NPRS 
enzymes is not so clear but some general inferences can be drawn.  The general organization of 
domains in linear NRPSs is made up of sequential A-T-C modules: A-T-C--A-T-C--A-T-C… 
etc. In iterative NRPSs, each domain is reused and the generated SM peptide is composed of 
repeating amino acid subunits; these systems are generally considered linear with iterative 
function near the C-terminus.  The C-terminus of iterative NRPSs may contain multiple T and/or 
C domains presenting as C-A-T--C-A…T-T-C or A-T-C--A-T…C-A-T-C-T-C-T-C.  With non-
linear systems, domains can be used once or multiple times which makes prediction of the SM 
difficult.  The domain organization of these systems is highly varied for example: A-T-E-C--A-
C-A-C-A-C--A-T-E-C-T-C-T and C-A--T-A-T-C--A-T-E-C--A-T-E [2, 68].    
Minimal domains tend to appear together as a module, fused together in fungi while in 
bacteria they can be separate entities [69]. Optional domains may also be present within NRPS 
modules generating further product diversity.  These domains can include some of the domains 
present in PKSs (MT, Te, and reductases) but also domains unique to NRPSs like epimerization 
(E) domains converting amino acids from the L to D configuration and cyclization (Cyc) 
domains catalyzing cyclization reactions in the nascent peptide chain [50, 70] (Figure 5).  
Some NRPS enzymes hold to the rule of collinearity.  This rule states that the amino acid 
sequence of a non-ribosomal peptide product is determined by the structure and sequence of the 
modules and their domains from its parent NRPS.  The collinearity rule generally applies to the 
linear NRPSs class only and can allow  prediction of peptide length and composition  from the 
order of the domains, the amino acid substrate specificity of the individual A domains in each 
module and the order of the modules themselves [50, 70].  This rule has been used to predict the 
structure of novel compounds from NRPS A domain sequences. For example, orphamide A was 
predicted from the protein sequence of A domains, and subsequently isolated and verified [71]. 
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1.4.2.1 General NRPS assembly of non-ribosomal peptides (NRP) in fungi 
 
In linear models, the initial step in NRP synthesis is the selection of an amino acid by the 
A domain of the first NRPS module.  The selected amino acid is converted into an aminoacyl-
AMP derivative by the action of the A domain and ATP hydrolysis.  The adenylated amino acid 
is transferred to the T domain, which is activated by the addition of a phosphopantetheinyl (PPT) 
arm by a PPTase; much like the ACP domain in PKS enzymes.  Next the selection of another 
amino acid by the A domain of the second module is carried out and subsequently transferred to 
the T domain of that module.  The C domain of the second module carries out the amide bond 
formation between the first T domain and the second.  The reactions proceed in the same manner 
across subsequent modules until peptide release sometimes aided by a TE domain.  Optional 
domains can also be present. Epimerization domains can carry out reconfigurations of stereo 
centers while Cyc domains facilitate cyclization reactions in the nascent peptide (Figure 6).  This 
sequence of events accounts for why most linear NRPS initiation modules lack a C domain since 
the condensation reaction between the first and second modules is catalyzed by the C domain in 




Figure 6. NRPS peptide assembly overview.  Activation of the T domain by a PPTase through 
phosphopantetheinyl transfer (A).  The A domain selects an adenylated amino acid and transfers 
it to the T domain (B).   The C domain forms a peptide bond between one amino acid and 
another amino acid selected by a downstream module in the same way as the initial module (C).  








1.4.3 HPN, NRPS-like and PKS-like structural organization 
 
Hybrid PKS-NRPS enzymes in filamentous fungi can take two forms.  One form has both 
a PKS and NRPS enzyme produced by separate genes in the same cluster.  These backbone 
enzymes ultimately fuse their products into a single hybrid polyketide-non ribosomal peptide. 
The HPN generating pneumocandin is an example of this form, fusing a polyketide with amino 
acid residues [45, 50].  The other HPN form derives from a single gene that encodes both a PKS 
and an NRPS module.  The HPN enzyme that produces pseurotin and equisetin are two examples 
of this form [42, 46, 50] (Figure 7).  Fused HPNs typically start with a PKS module followed by 
a single NRPS module with the domains C-A-T.  The PKS portion of the HPN also tends to be a 
highly reducing class, but partially reducing forms are also known.  Production of hybrid 
molecules proceeds as previously described for the polyketide and peptide components.  The 
attachment of the polyketide chain to the selected amino acid is accomplished by a C domain of 
an NPRS module [74]. 
 
Figure 7. General structure of both HPN backbone enzyme forms. Blue and red represent 
minimal and reducing domains respectively.  Squares and circles respectively represent the PKS 
and NRPS domains.  Modified from Kehr, J.C., et al [51]. 
 
Genes encoding type 1 iterative PKS and all NRPS class enzymes that are missing one or 
more minimal domains are found in fungi [75, 76]. The NRPS enzymes missing minimal 
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domains are referred to as NRPS-like while PKS enzymes missing at least one minimal domain 
are referred to as PKS-like.  The NPRS-like enzymes can still participate as backbone enzymes 
in SM biosynthesis.  This has been recently demonstrated in the production of the dipeptide 
atromentin fusing two modified tyrosine residues [77]. Unlike the type III PKS and NRPS-like 
backbone enzymes, PKS-like enzymes have no known function to our knowledge but may be 
active from trans-acting single domain surrogates like in the case of trans AT domains in bacteria 
[78].  Their genes may in fact be remnants of full-length PKS or HPN genes whose products 
contain at least the minimal domains.  For example, a PKS-like gene found in the genome of A. 
niger ATCC 1015 appears to be remnant of the PKS gene known to be involved in ochratoxin 
production in A. niger CBS 513.88 [75].   
1.4.4 Fatty acid synthase structural organization and assembly 
 
The FAS enzymes of filamentous fungi can be involved in both primary and secondary 
metabolism. However, distinct forms of FASs are used for each type of metabolism [28].  The 
domain complement of FAS is very similar to PKS enzymes with an additional PPT domain that 
for PKS enzymes is usually a separate enzyme encoded by a separate gene [79]. Only one known 
iterative PKS from Saccharopolyspora erythraea appears to violate this rule [80]. The 
malonyl/palmitoyl transferase (MPT) domain in fungal FAS enzymes is another domain not 
present in PKS enzymes.  Its function is to transfer a hydrocarbon chain back to a coenzyme A 
(CoA) following the completion of chain elongation [80, 81].  Lastly, unlike the PKS, the fungal 
FAS exists as a heterodimer consisting of an alpha subunit with domains MPT-ACP-KR-KS-
(PPT) and a beta subunit with domains AT-ER-DH-MPT [80].   
Fatty acid assembly is analogous to polyketide assembly using acetyl-CoA starter and 
malonyl-CoA extender units to build hydrocarbon chains [82].  The FAS can also incorporate a 
variety of starter units like the non-reducing PKS [83].  A notable difference between these two 
classes of backbones is that chain elongation in FASs typically occurs after full reduction of the 
keto group from the malonyl unit to a single carbon-carbon bond while in PKSs extension can 




1.4.5 Structure and function of tryptophan dimethylallyl transferases and sesquiterpene cyclases. 
 
The DMAT and sesquiterpene cyclase enzymes in contrast to the preceding backbone 
enzymes contain only one catalytic/biosynthetic domain.  Despite being single domain enzymes, 
the genes coding for these two backbone classes are also found in SM gene clusters like PKS and 
NRPS genes (68, 69).  In terms of core molecule production, the DMAT enzymes produce 
alkaloids while sesquiterpene cyclases produce cyclized terpenoid compounds.  Biosynthesis by 
DMATs and sesquiterpene cyclases differ in the backbone metabolites they generate.  The 
DMAT generates a modified tryptophan residue (attached dimethylallyl group), while the 
sesquiterpene cyclase cyclizes an assembled sesquiterpenes such as farnesyl in tricothecene 
biosynthesis [85, 86]. 
1.5 Bioinformatics approaches to identifying and annotation SM clusters 
 
With the advent of genomics, many aspects of annotation have become automated.  
Today, automated annotation includes a host of software applications to identify SM clusters.  
These applications use common features from experimentally characterized SM clusters to 
define new clusters in sequenced genomes.  For instance, software such as SMURF and 
antiSMASH locate backbone enzyme genes in genome sequences and work outward adding 
neighbouring tailoring genes found in experimentally verified clusters to the cluster being 
defined if they appear nearby [87, 88].  Agreement between various SM cluster defining software 
can be problematic and ultimately requires manual input to refine the cluster edges (Figure 8) 
[27].  As a first approach, however, software such as SMURF and antiSMASH can reduce the 
time needed to locate and define clusters compared to solely manual methods [87, 88].  
Additionally, applications such as Sybil use orthology of SM gene clusters between sequenced 
genomes of different species to help guide manual definition of their boundaries.  Using Jaccard 
clustering methods (BLASTP queries of all proteins from all the selected genomes against each 
other) Sybil identifies orthologues between species.  This is based on the premise that all the 
genes contained in a specific SM cluster shared between different species (%ID’s between 
species > 80%) will produce the same SM and be fully retained from species to species.  For 
instance, two clusters from two species matched up in Sybil show that seven of the genes 
matchup between them (%ID for each gene >80%) genes outside these seven do not match.  
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Based on this observation the cluster in both species has only seven genes and the boundaries can 
now be drawn  [89].  Sybil provides graphical results to help reveal possible clusters edges 
defined at junctions where the orthology ends in all matched genomes (Figure 8).   
 
 
Figure 8. Sybil display of the experimentally determined cluster producing gliotoxin in 
Neosartorya fischeri compared to other genomes (A).  The complete cluster appears in two A. 
fumigatus strains (top and middle) with the junctions of non-orthologous and orthologous genes 
(either ends of the red bar) defining the experimentally determined edges of the gliotoxin cluster.  
The Sybil result in B shows an unknown cluster predicted using the same method that showed 
proof of concept in A; the edges are again defined at orthologous/non-orthologous junctions ends 






1.5 Filamentous fungi produce thousands of “orphan compounds” and contain a wealth of 
“cryptic” SM clusters 
 
Filamentous fungi are prolific producers of natural products with identified compounds 
numbering in the thousands [90].  The genes and/or gene clusters responsible for the production 
of many of these compounds are unknown.  Compounds for which the biosynthetic processes are 
unknown are referred to as “orphan compounds” [91].  Many of these orphan compounds have 
useful properties and determining their genetic underpinnings could allow their overproduction.  
For example, the tensyuic acids and hexylitaconic acid are orphan compounds discovered in A. 
niger that have a number of useful biological properties.  Hexylitaconic acid, known since the 
1980’s has been shown promote plant growth [92] while tensyuic acid C has shown potential as 
an anti-parasitic and antibiotic compound [93, 94].  Determining the biosynthetic pathway for 
these compounds could help devise strategies for their overproduction.  This has been shown 
recently in Cercospora nicotianae where knowledge of the biosynthetic pathway for cercosporin, 
a polyketide, was used to produce mutants which accumulate various precursor compounds [95].  
The ability to overproduce these useful SMs can reduce the cost of their production by reducing 
the need for purification and improve their adoption in health, environmental and industrial 
applications.   
A key step in pathway reconstruction is to locate the parent gene cluster of a 
compound(s) to determine the enzymes involved.  Many of the clusters annotated in the 
sequenced genomes of fungi have unknown functions. These clusters are referred to as “cryptic” 
[96].  By annotating the set of SM clusters in a particular species, the search for the genetic 
underpinnings of particular orphan compounds can be narrowed down.   Then, through analysing 
the tailoring and backbone genes within clusters, their functions can be used to match a particular 
orphan compound with its cryptic cluster.   In a recent work, a P450 monooxygenase and an o-
methyltransferase enzyme was used as a guide to a specific non-reducing PKS containing cluster 






1.6 Aspergillus niger NRRL3 as a model fungus for SM research 
 
With 228 of its 13870 genes having gene onotology references to secondary metabolism 
[27], A. niger has good potential for identifying gene clusters involved in the production of 
orphan compounds as well as for novel compound discovery. Compared to other well studied 
Aspergilli, the number of SM clusters in A. niger (84) exceeds that annotated in the genomes of 
A. nidulans (66), A. fumigatus (34), and A. oryzae (73) making it a good candidate for the study 
of SM production.   Aspergillus niger and related species are also known to produce over 140 
SMs 68 of which have not been tied to their gene clusters (Table 2.) [98].  This leaves the 
biosynthetic pathways for many of these orphan compounds available for characterization.    
 
Table 2. Secondary metabolite compounds isolated from Aspergillus niger. 
Polyketides Orphan Non ribosomal peptides Orphan 
* 8′-O-Demethylisonigerone 
 
Malformin A1  X 
* 8′-O-Demethylnigerone  
 
Malformin A2 X 
* 10,10′-Bifonsecin B 
 
Malformin B1a  X 
* Aurasperone A  
 
Malformin B1b  X 
* Aurasperone B  
 
Malformin B2  X 
* Aurasperone C  
 
Malformin B3 X 
* Aurasperone D 
 
Malformin B4  X 
* Aurasperone E  
 
Malformin B5  X 
* Aurasperone F  
 
Malformin C X 
* Aurasperone G 
 
Cyclo-l-Ala-l-Leu X 
* Asperpyrone A  
 
Cycloleucomelon X 
* Asperpyrone B 
 
Atromentin X 
* Asperpyrone C  
   








Yanuthone A  
 
















* Fonsecin (TMC-256B1) 
 
Nafuredin X 













* Isonigerone  
 
1-Hydroxyyanuthone C  
 
* Nigerone 






Aspernigrin A X 
* TMC-256C1 
 






Tensidol A X 
** Orlandin  
 
Tensidol B X 
** Kotanin 
 
Nygerone A X 
** 7-Hydroxy-4-methoxy-5-






X Nigerazine A X 
3′,4′,5,7-Tetrahydroxy-8-methoxy 
isoflavone 
X Nigerazine B  X 
4,9-Dihydroxyperylene-3,10-quinone X Diketopiperazine dimer X 




Asnipyrone A  X Asperazine X 
Asnipyrone B X 
  
Asperyellone X PK/NRP hybrids Orphan 
Azanigerone A [100] 
 
Pyranonigrin A  
 
Azanigerone B [100] 
 
Pyranonigrin B  
 
Azanigerone C [100] 
 
Pyranonigrin C  
 
Azanigerone D [100] 
 
Pyranonigrin D  
 
Azanigerone E [100] 
 
Pyranonigrin E [47] 
 












Differenol A  X Nigerasperone A X 
Fumonisin B2 
 
Nigerasperone B X 
Fumonisin B4 
 
Nigerasperone C X 
Funalenone  X Aspergillin  X 
Iso-T-2 toxin X 
  
Orobole X Fatty acids Orphan 




Nigerapyrone B [61, 101] X 2-hexylcitric acid X 
Nigerapyrone C [101] X Hexylitaconic acid X 
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Nigerapyrone D [101] X Tensyuic acid A [93] X 
Nigerapyrone E [101] X Tensyuic acid B X 
Nigerapyrone F [101] X Tensyuic acid C X 
Nigerapyrone G [101] X Tensyuic acid D X 
Nigerapyrone H [101] X Tensyuic acid E X 
Nigerloxin X Tensyuic acid F X 
































Glycolic acid  
 
  
Hydroxypyruvic acid  
 
  
Fumaric acid  
 
  
p-Methoxyphenylacetic acid X 
  
Phenoxyacetic acid  X 
  
Phenylacetic acid X 
  
Pisolithin B  X 
 
1
Table modified from Nielsen, K.F., et al [98]. 
2
Orphan compounds are marked with an X.   
3
Compounds without associated reference were sourced from Nielsen, K.F., et al [98]. 
4
Where available, compounds have been categorized according to Nielsen, K.F. et al [98] or 
from literature searches.  All other compounds categorized based on typical backbone molecular 
structure and composition for each class. 
  * Compound is produced by albA/fwnA PKS and its associated tailoring enzymes based on 
literature and core structure similarity [103-105].   
** Compound is produced by the ktnA PKS cluster based on literature and core structure 





1.7 Expression, analysis and biosynthetic pathway reconstruction of SM clusters 
 
While in silico cluster definition can serve as an initial approximation of the genes within 
a given cluster, ultimately experimental verification is required to test the robustness of 
predictions.  Expression data in the form of RT-PCR or RNA-seq can be used to support cluster 
predictions [100, 106].  Transcriptomic data from RNA-seq may also be useful in identifying 
non-clustered genes involved in secondary metabolite production since it takes into account gene 
expression data of the entire genome.   
The expression of SM clusters in nature can occur from a wide variety of internal and 
external stimuli [107].  Under laboratory conditions however, many SM clusters remain silent 
and activating their expression can prove challenging [108].  Attempts to induce cluster 
expression have met with some success through methods such as overexpressing a clustered 
transcription factor or a global transcription factor [100, 109], modification of the epigenome 
[110], or heterologous expression in other hosts including Saccharomyces cerevisiae, A. nidulans 
and A. oryzae [102, 111].  Developing strategies to solve the expression problem is an active 
area of research that may prove beneficial in the discovery of novel compounds and serve as a 
means to overproduce valuable known compounds.  Alternately, the determination of the clusters 
responsible for producing known toxins may provide a means for their removal from industrially 
relevant organisms like A. niger used in the production of food additives [12].   Malformin for 
instance, which causes cell-cycle arrest in mammalian cells,  has been known to be produced by 
A. niger since at least the 1950’s [112] but the determination of the underlying genes responsible 
for its production remain elusive.   
1.8 Rationale for pursuing research in fungal secondary metabolism 
 
Research into fungal secondary metabolism is of vital importance not only to human 
health but also to the various chemical products used in human society.  Understanding the 
mechanisms of SM production has the potential to reduce health risks in microbial food 
production, develop new lifesaving drugs (particularly as antibiotic resistance is becoming a 
health issue), and increasing production of those drugs and other commodities.  These are just 




1.8.1 Toxic substances can be produced from organisms used in industry for food production 
 
Toxins produced by fungi can pose public health risks, particularly when fungi are used 
in industry [15, 113].  The elimination of these toxins may mitigate some of the risks.  For 
example, the filamentous fungus Aspergillus niger is grown in large fermentation vats and its 
metabolic processes are exploited for the production of a variety of  food additives like citric acid 
[12].  Some strains however also produce a variety of unwanted toxins such as fumonisin and 
ochratoxin.  Given the consumption of food additives produced in A. niger, compounds like 
fumonisin and ochratoxin pose potential health risks to people and livestock [113].  With the 
prior annotation of the fumonisin gene cluster in A. niger and other species of filamentous fungi, 
the production of fumonisins may potentially be eliminated by targeted gene deletion [114].  
However, while true for some toxins, many toxins produced in A. niger as well as other 
filamentous fungi used in industry have no known genetic underpinnings and still pose potential 
risks to public health.   
1.8.2 Secondary metabolism and antibiotic resistance 
 
The discovery of novel compounds is becoming an increasing priority in university 
research particularly with respect to antibiotics since the pharmaceutical industry has begun 
diverting funds to more profitable areas [115, 116].  Over the last few decades two main issues 
have been occurring in the public health field that are prompting investigations into the current 
state of  available antibiotics.  First, the number of new antibiotics being discovered has been 
falling [116] and second the rates of bacterial resistance to current antibiotics is on the rise [117].  
In fact, bacterial species like methicillin resistant Staphylococcus aureus are now resistant to 
many antibiotics resulting in several difficult to treat diseases [118].  These two aspects of an 
unfolding health crisis are generating a pressing need to discover new compounds.   Current 
research in this area is not keeping pace with the build-up of resistance by microorganisms to 
existing antibiotics [119]. 
One potential avenue to finding new antibiotics is to examine the secondary metabolism 
of microorganisms.  Many of the antibiotics discovered in the past, like penicillin, are produced 
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from the secondary metabolism of fungi [120]. With the advent of genomics, recently sequenced 
genomes of various fungi reveal that they possess genes capable of generating  numerous new 
secondary metabolites, some of which could be potential antibiotics [121].  This fact alone 
illustrates that research into secondary metabolism is a potential “gold mine” for not only 
generating new antibiotics, but also other novel compounds.  
The threat of not just antibiotic resistance but other medical issues as well, is bringing 
pressure to bear on researchers to discover novel compounds.  One advantage of using 
filamentous fungi for novel compound discovery is the number of orphan clusters within their 
genomes.  To put this into perspective, the genome of A. niger contains at approximately 80 SM 
clusters (strain dependent) but only about 10%, from diverse SM classes, have had their 
metabolic products experimentally determined [27, 47, 97, 99, 100, 102, 122-124].  Figure 9 
shows the variation in chemical structure of some of the known products generated by A. niger 
including orphan compounds.   
 
 
Figure 9. Secondary metabolites (A) and toxins (B) produced by Aspergillus niger.  Orphan 




1.8.3 Manipulation of SM pathways can overproduce desired products 
 
Many secondary metabolites are complex molecules and consequently their chemical 
synthesis can be very expensive.  For this reason, having organisms like A. niger produce desired 
SMs can substantially cut costs of production [125].  Enter metabolic engineering; using the 
knowledge from experimentally verified pathways, researchers are now able to manipulate these 
pathways on a genetic level towards accumulating desired compounds.  Varieties of methods and 
techniques have been employed to accomplish this goal.  These include pathway gene deletions 
resulting in terminations at particular biosynthetic steps, elimination of competing pathways by 
gene deletion to increase the resources available for the desired pathway and de novo pathway 
design by combining enzymes from similar pathways to generate compounds in non-native hosts 
[126].   
1.10 Objectives of this study 
 
Addressing the challenges of natural product production, we propose an overall objective 
to develop a strategy to discover the genetic underpinnings of orphan compounds and use this 
information to engineer strains that can overproduce their intermediates as well as the 
compounds themselves.   
This overarching objective is broken down into four sub-objectives.  First to identify and 
catalog the clusters and their genes that are responsible for the production of secondary 
metabolites in the genome of A. niger NRRL3.  Secondly, to overexpress transcription factor 
genes predicted to regulate SM clusters (clustered transcription factors) within A. niger NRRL3 
in an effort to generate their secondary metabolites.  Thirdly, to reconstruct biosynthetic 
pathways for compounds for which the genetic underpinnings are currently unknown.  Lastly, to 
generate deletion mutants based on reconstructed pathways to accumulate intermediate 
compounds and test the robustness of our pathway reconstruction method by predicting the 





Materials and Methods 
2.1 Bioinformatics methods 
2.1.1 Backbone enzyme identification 
 
All backbone enzymes were initially identified via BLASTP searches using previously 
characterized backbone enzyme sequences from other Aspergilli as queries (E-value ≥ 1x 10-5).  
All hits were evaluated for acceptance into their respective categories by protein domain content 
using the online applications Pfam (http://pfam.xfam.org/), conserved domain database (CDD) 
(http://www.ncbi.nlm.nih.gov/cdd/), and InterProScan 5 
(http://www.ebi.ac.uk/interpro/search/sequence-search).  Domain annotations for each enzyme 
were accepted when at least two databases agreed on annotation.  Sequences were accepted as 
PKS, NRPS and HPN enzymes when at least all respective minimal domains were present with 
the exception of PKS NRRL3_01804 whose ACP domain does not have a complete 
GX(H/D)S(L/I) (GP) amino acid motif but which still may be functional based on previous 
work with non-canonical ACP domains [29, 127].   The PKS-like and NRPS-like enzymes were 
accepted when at least two databases agreed on at least two domains which are contiguous for 
specific enzyme categories and at least one was a minimal domain.  For domains which were not 
documented in the domain databases, multiple sequence alignments were performed to confirm 
the presence of previously published amino acid motifs and conserved residues.  This process 
was limited to start unit acyl transferase [128] (SAT), product template [129] (PT) and FAS ACP 
domains [80].   
An additional round of BLASTP searches was subsequently carried out using isolated 
domain pairs (from enzymes in the first round) which appear contiguously within enzyme 
categories and contain at least one minimal domain (E-value cut-off of 1x10
5
).  This was done to 
find more backbone enzymes by reducing gap penalties from BLAST alignments. I surmised that 
using domain pairs that are always contiguous in each backbone class would have fewer and 
shorter gaps when used as a query sequence compared to using the full backbone enzyme 
incurring small gap penalties.  For instance, a BLAST search using a full non-reducing PKS 
against the genome would incur a gap penalty when aligned with a highly reducing PKS due to 
the intervening reducing domains between the AT and ACP domains in the highly reducing PKS.  
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Even a highly reducing PKS may incur gap penalties when aligned with another such PKS from 
uncommon domains like MT or alcohol dehydrogenase domains.  This process was particularly 
helpful with NRPS enzymes given the higher variability in their domain organization than PKS 
enzymes.  
For FAS enzymes, given the lack of variation in their domain organization compared to 
PKS enzymes, the FAS alpha and beta subunit enzymes were accepted into their respective 
categories if the prospective enzyme contained the general domain architecture (the PPT domain 
notwithstanding) of the fungal FAS alpha or beta domains as outlined by Jenni, S. et al [80].  All 
DMAT, sesquiterpene cyclase, and type III PKS single domain enzymes were accepted based on 
InterProScan families (IPR017795, IPR024652 and IPR011141 respectively) and CDD domains 
(PT-DMATS_CynD, Isoprenoid_Biosyn_C1 and BH0617 respectively). 
2.1.2 Backbone enzyme comparison between A. niger NRRL3 and A. niger CBS 513.88 
 
To compare closely related strains in terms of secondary metabolite genes, protein 
sequences of identified enzyme backbone classes from A. niger NRRL3 as well as A. niger CBS 
513.88 were used as queries against each other’s genomes to identify counterparts and unique 
enzymes between the strains.  Annotated enzymes from A. niger CBS 513.88 were obtained from 
the AspGD website (http://www.aspergillusgenome.org/) Backbone enzymes with %ID ≥ 85 (E-
value ≥ 1x 10-5) from BLASTP queries were designated counterparts and all others were 
considered unique to either strain.   
2.1.3 Backbone enzyme remnant and remnant cluster analysis 
 
In order to determine if backbone-like enzymes had complete counterparts in other 
species, PKS-like and NRPS-like enzyme sequences as well as all possible singlet domain types 
in the multi-domain secondary metabolite backbone enzymes were used as queries against the 
fungal genomes available at the AspGD website (%ID ≥ 50, E-value ≥ 1x 10-5)).  Any backbone-
like enzyme which had a full counterpart in another species was labelled as a remnant.   
We next examined the homology of other genes around identified remnant backbone 
genes in species with complete counterparts to identify missing, if any, SM cluster genes.  
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Homology was visualized using the Sybil online application at the AspGD website 
(http://aspgd.broadinstitute.org/cgi-bin/asp2_v3/shared/index.cgi?site=asp2_v9).  Since the Sybil 
application could not find homologues of the remnant enzymes (possibly due to their highly 
truncated structure), accessory enzymes in their vicinity were used as anchor points for Sybil 
homology searches.  
2.1.4 Secondary metabolite cluster definition 
 
Secondary metabolite clusters were defined using the clusters which were previously 
annotated in A. niger CBS 513.88 as a reference [27].  These clusters were modified to 
incorporate our updated gene annotation data and took precedence over the original annotations 
including those defined by Sybil synteny alignments.  Apart from automated backbone discovery 
(by SMURF and antiSMASH) and syntenic cluster definition, all methods for cluster definition 
in this study followed those outlined for CBS 513.88 [27] for those clusters whose backbone 
enzymes were unique to this study. 
2.1.5 Assignment of secondary metabolites to annotated SM clusters and mitochondrial peptide 
localization sequences 
 
Metabolic products were assigned to specific PKS, NRPS and HPN clusters based on 
experimentally defined orthologous clusters or backbones.  Experimentally defined backbone 
enzymes with known clusters and metabolic products were used as a query sequence for 
BLASTP against the NRRL3 genome.  The experimentally defined backbone enzymes which 
had a match in the NRRL3 genome (%ID ≥ 40%, query coverage ≥ 80%) were set aside and 
their accompanying accessory enzymes were then queried against the NRRL3 genome.  
Backbone and accessory enzymes from literature were assigned an A. niger NRRL3 counterpart 
where % sequence identity was ≥ 80%, 50% and 40% (E-value ≥ 1x 10-5) for other A. niger 
strains, other species of Aspergillus, and non-Aspergillus filamentous fungi respectively (query 
coverage ≥ 80%).  Where BLASTP top hits from other genomes were co-localized in A. niger 
NRRL3, the group was accepted as an orthologous cluster.   Lastly, to determine subcellular 
localization sequences for mitochondrial proteins, we used the targetP 1.1 online application 
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(http://www.cbs.dtu.dk/services/TargetP/) to look for mitochondrial targeting and processing 
peptides in protein sequences [55]. 
2.2 Methods for alkyl citric acid cluster investigation 
2.2.1 Strains and culture conditions 
 
Aspergillus niger PY11 (cspA− pyrG− ΔGla::hiG), a derivative of NRRL3, was used for 
all fungal transformations and overexpression studies.  The culture conditions and transformation 
protocol used for this study have been described previously [130].   The DH5α strain of E. coli 
was used for propagation of cloned plasmids. For metabolite production, conidia (2x10
6
 
conidia/mL) from A. niger transformants were inoculated into liquid MM “J” medium [130] and 
incubated without shaking at 30°C for 5 days.  For transcriptome analysis, conidia at 2x10
6
/mL 
were inoculated in minimal medium [131] containing 2% fructose, 0.1% yeast extract and 0.1% 
casamino acids.  Cultures were incubated at 30°C and with shaking at 220 rpm. After 24 hours of 
growth, mycelia were collected by gravity filtration using Miracloth (EMD Millipore – 475855, 
Darmstadt, Germany) through a Buchner funnel. Following washing with water, approximately 
one teaspoon (~5 mL) of mycelia was transferred to 50 mL of minimal medium containing 2% 
maltose. Shaking cultures containing the mycelia were incubated at 30°C and at 220 rpm for 2 
hours, harvested by filtration as above.  The harvested mycelia were then frozen in liquid 
nitrogen for RNA extraction. 
2.2.2 Construction of overexpression vectors 
 
Two plasmid vectors were constructed to overexpress the regulator genes within our 
defined clusters.  The difference between them is the marker gene used for selection of A. niger 
transformants (Figure 10).  In the first vector, the plasmid ANIp7 [132] was amplified by PCR 
using primers containing a 21-nucleotide adapter sequence (Figure 10, Table 3).  The plasmid 
insert transcription factor was prepared by PCR from genomic DNA obtained using a GeneJET 
Genomic DNA Purification Kit (Thermo K0721, Thermo Scientific, Grand Island, NY USA).  
Adapter sequences from insert and vector amplification primers were designed to be 
complementary allowing for annealing for ligation-independent cloning [133].  This vector was 
used for the initial screening to identify SM regulators and for transcriptome analysis. In the 
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second expression vector, the pyrG selection marker was replaced by an amdS selection marker 
(Figure 10, Table 3) and was used for overexpression of the NRRL3_11765 transcription factor 
to construct a strain which would subsequently be used for gene deletions.  Gene deletions were 




Figure 10. Overexpression cassette containing the NRRL3_11765 transcript ion factor.  The 
cassettes contain the bacterial ampicillin selection marker (bla), a promoter/terminator (GlaPr, 
GlaTt) and the fungal selection markers pyrG for the initial screen and amdS for expression in 
deletion strains.  Numbered bent arrows indicated the primers (with the adapter sequences at the 
5’ end) used for construction of the plasmid and insert fragments; refer to numbers in Table 3 for 










Table 3.  The list of primers used for plasmid and gene deletion cassette assembly.   Underlined 
sections represent adapter sequences. 
No. Primer Name Sequence 5' --> 3' 
1 NRRL3_11765 Fw  TACTTCCAATCCAATCCATTTGACGATATGGCTACTCCCCGCGCATC 
2 NRRL3_11765 Re TTATCCACTTCCAATCCATTTGTCACTGCATCAATCCCAACGCAG 
3 ANIp7 Fw AAATGGATTGGAAGTGGATAACTTAATTAAGTTTAAACG 
4 ANIp7 Re AAATGGATTGGATTGGAAGTACTGATCTAGCGTGTAATG 
5 5' NRRL3_11766 Fw AATTCCCAGCTCCAAGTGC 
6 5' NRRL3_11766 Re AAATGGATTGGAAGTGGATAACGGAGACTTCTGATGAATATGTGG 
7 3' NRRL3_11766 Fw AAATGGATTGGATTGGAAGTACGCCAATCTTGACCAGGATG 
8 3' NRRL3_11766 Re  ACATTTGGTCGGGATAACAACAAC 
9 pyrG sel. marker Fw TTATCCACTTCCAATCCATTTGCCCCTTTTAGTCAATACCG 
10 pyrG sel. marker Re TACTTCCAATCCAATCCATTTGCGCAACTTCCTCGAGAAC 
11 NRRL3_11766 ext Fw ATTCTCACCTATGCAGGCAC 
12 NRRL3_11766 ext Re  CCATGCTCGAGGGTAAAAGC 
13 5' NRRL3_03750 Fw AAATCCGCATGAAGAGGACC 
14 5' NRRL3_03750 Re AAATGGATTGGAAGTGGATAACTCCAGGACAAACAAGAGGCAC 
15 3' NRRL3_03750 Fw AAATGGATTGGATTGGAAGTACCGTGGAGTATTTGTTCGGAATG 
16 3' NRRL3_03750 Re AGTTAGACTGGTATTCATTAAGGAGAG 
17 NRRL3_03750 ext Fw ACTTACCATTGCTTTAGTGATCC 
18 NRRL3_03750 ext Re GACTTTCCTGACTTGCAACTC 
19 5' NRRL3_08383 Fw GGGATTCAAGGGGTAAATGGAAC 
20 5' NRRL3_08383 Re AAATGGATTGGAAGTGGATAACCCCTCATAGCACGACGAAATC 
21 3' NRRL3_08383 Fw AAATGGATTGGATTGGAAGTACGAGGAATGGAATCTACTTTTGGTG 
22 3' NRRL3_08383 Re TTGTTGATTTCCGGCGTAAGC 
23 NRRL3_08383 ext Fw CTGGTTGGATCGTTGTTTTG 
24 NRRL3_08383 ext Re TCTCATTCCTCATCCCCTC 
   
2.2.3 Gene deletion cassette construction and verification in A. niger NRRL3_11765 
overproducing strain 
 
Three linear cassettes were designed to delete a 2-methylcitrate dehydratase gene 
(NRRL3_11766), a monooxygenase gene (NRRL3_03750), and an o-methyltransferase gene 
(NRRL3_08383) thought to be involved in NRRL3_11765 upregulated pathway (Figure 11-13).  
The cassettes consisted of two homologous DNA sequences flanking each target gene and fused 
with an intervening pyrG selection marker by overlap PCR.  The overlap PCR used the same 
primer adapter sequence as described in section 2.2.2 (Table 3).  Genomic sequence information 
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used in this study was obtained from the A. niger genome resource at www.fungalgenomics.ca. 
Deletion mutants were screened by PCR using primers binding upstream of the 5’ flank and 
















Figure 11. (A) Deletion cassette for NRRL3_11766.  Crossed lines indicate regions of 
homologous recombination between the cassette sequence (top) and the target gene sequence 
(bottom).  Genome coordinates of 5’ and 3’ flanks are shown above each flank.  A gray shaded 
box in the target gene sequence indicates the area of overlap between the 3’ flank and 
NRRL3_11766.  Numbered arrows within cassettes indicate the primers used for PCR 
amplification of DNA fragments for their assembly (refer to numbers in Table 3 for primer 
sequences).   Numbered arrows outside of 5’ and 3’ flanks indicate primers used for PCR 
verification of homologous recombination in transformants.  Bent arrows indicate primers with 
adapter sequences. (B) Gene ruler 1kb plus.  (C) Result of PCR product screen for the 





Figure 12 (A) Deletion cassette for NRRL3_03750.  Crossed lines indicate regions of 
homologous recombination between the cassette sequence (top) and the target gene sequence 
(bottom).  Genome coordinates of 5’ and 3’ flanks are shown above each flank.  A gray shaded 
box in the target gene sequence indicates the area of overlap between the 3’ flank and 
NRRL3_03750.  Numbered arrows within cassettes indicate the primers used for PCR 
amplification of DNA fragments for their assembly (refer to numbers in Table 3 for primer 
sequences).   Numbered arrows outside of 5’ and 3’ flanks indicate primers used for PCR 
verification of homologous recombination in transformants.  Bent arrows indicate primers with 
adapter sequences. (B) Gene ruler 1kb plus.  (C) Result of PCR product screen for the 




Figure 13. Deletion cassette for NRRL3_08383.  Crossed lines indicate regions of homologous 
recombination between the cassette sequence (top) and the target gene sequence (bottom).  
Genome coordinates of 5’ and 3’ flanks are shown above each flank.  A gray shaded box in the 
target gene sequence indicates the area of overlap between the 3’ flank and NRRL3_08383.  
Numbered arrows within cassettes indicate the primers used for PCR amplification of DNA 
fragments for their assembly (refer to numbers in Table 3 for primer sequences).   Numbered 
arrows outside of 5’ and 3’ flanks indicate primers which were used for PCR verification of 
homologous recombination in transformants.  Bent arrows indicate primers with adapter 
sequences. 
 
2.2.4 Transcriptome sequencing and analysis 
 
Total RNA was extracted from frozen (by liquid nitrogen) mycelia using TRIzol reagent 
(Thermo Scientific, Grand Island, NY USA) as described [134].   A cDNA library was 
constructed using an Illumina TruSeq Stranded   mRNA Sample Preparation Kit and sequenced 
to generate 100-bp reads on an Ilumina HiSeq 2000 system at the McGill University Génome 
Québec Innovation Centre.  Differential gene expression analysis was carried out using the 
DEseq Bioconductor software package [135].  Genes were considered significantly up or down 
regulated due to NRRL3_11765 overexpression when p-value < 2x10
-4
. Genes expressed at very 
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low levels, below 10 fragments per kilobase of transcript per million (FPKM), in both the control 
and overexpression strains were removed from analysis.   
2.2.5 Preparation of metabolites for mass spectrometric analysis 
 
To prepare extracellular metabolites in growth media for mass spectrometry, mycelia 
were removed following cultivation by centrifugation at 16,000 x g for 45 minutes.  The 
supernates were transferred to fresh tubes and mixed with an equal volume of 99% purity grade 
cold methanol (CH3OH) (-20°C). After resting on ice for 10 minutes, the samples were 
centrifuged at 16,000 x g for 45 minutes to remove precipitated proteins.  The resulting 
supernates were transferred to fresh tubes and mixed with an equal volume of 0.1% formic acid.   
For the preparation of intracellular metabolites, fungal mycelia were ground with liquid 
nitrogen by mortar and pestle.  The ground powder was dissolved in water and sonicated while 
on ice for 5 minutes, with alternate cycles consisting of 5 seconds off and 15 seconds on.  After 
sonication, 1 mL of the samples were centrifuged at 16,000 x g for 45 minutes and the supernates 
were prepared for mass spectrometry analysis as described for extracellular metabolites and 
transferred to amber vials with inserts for HPLC and mass spectrometry (Wheaton Co, Product 
09-2200-101, Millville, NJ USA). 
2.2.6 Analysis of metabolites by mass spectrometry 
 
Electrospray LC-MS analyses were performed on a 7-Tesla Finnigan LTQ-FT-ICR mass 
spectrometer (Thermo Electron Corporation, San Jose, CA).  Ionization voltage used was 4900 V 
in positive mode and 3700 V in negative mode.  Scan range was from 100 to 1400 m/z at a 
50000-resolution setting.  The solvent delivery system used was a Series 200 auto sampler and 
micropump (Perkin Elmer, Waltham, MA).  Injection volume was 10 µL and flow rate was 250 
µL/minute.  Reversed-phase liquid chromatography (RPLC) separation was performed using an 
Eclipse C18 3.5 µm, 2.1 x 150 mm column (Agilent, Santa Clara, CA).  The solvents used to 
generate the gradient during reversed-phase liquid chromatography (RPLC) separation were 0.1 
% formic acid in water for Solvent A and 0.1% formic acid in acetonitrile for Solvent B.  The 
gradient was used to elute the metabolites: 5% B isocratic for 1 minute, increased to 95% B in 10 
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minutes, isocratic at 95% for 1 minute, decreased to 5% B in 0.1 minute, and isocratic at 5% for 
5.9 minutes.              
Total ion chromatograms, with a range of 190m/z – 300m/z, were generated using the 
XcaliburTM software version 2.2 (Thermo Scientific 2011).  Aligned peak identification and 
extracted ion chromatograms (EICs) construction were carried out using Maven (2011 version 
6.12) scanning at a minimum peak intensity threshold of 5x10
4
 and a mass tolerance of 5 ppm 
[136].  Peak identification was carried out primarily on positive mode mass spectra for 
consistency using a manually assembled database (“secondary metabolite database”) of 
secondary metabolites from literature searches. Negative mode EICs were used instead where an 
identified compound could not be detected above threshold in positive mode. 
2.2.7 Analysis by nuclear magnetic resonance (NMR) 
 
Secondary metabolites from A. niger overexpressing transcription factor NRRL3_11765 
(chaR
OE
) were extracted from 700 ml of culture with 1L of ethyl acetate (EtOAc) to remove 
sugars and other solutes from growth media. The extract was dried in vacuo to yield an oily 
material (6g) which was dissolved in 1 mL of chloroform (CHCl3), and then applied to a silica 
gel column (57 × 508 mm, 250g, Zeoprep 60, 40 - 60 mm). Elution factions included 100:0, 
100:1, 75:1, 50:1, 25:1, 1:1, and 0:100 (v/v) of CHCl3- CH3OH solvents, 250ml each. The 2-
carboxymethyl-3-hexylmaleic acid (5.3 g) compound was eluted in the two first fractions (100:0, 
100:1), while hexylitaconic acid (150 mg) and the hydroxylated form of hexylitaconic acid (200 
mg) were collected from fractions 75:1 and 25:1, respectively. Hexylcitraconic acid (100 mg) 
and the carbonylated form of hexylitaconic acid (6 mg) were eluted at fraction 50:1 in different 
collection tubes. All these SMs were dissolved in CDCl3 (Sigma-Aldrich) for structural 
investigation by NMR, except the hydroxylated hexylitaconic acid (a polar molecule), which was 
dissolved in CD3OD (Sigma-Aldrich) for later NMR investigation.  
Twenty millilitres of culture filtrate from the chaR
OE 
strain containing a 2-methylcitrate 
dehydratase deletion (NRRL3_11766) were extracted twice with 40 mL of EtOAc. The extract 
was dried in vacuo to a brown powder. Twenty four milligrams of the powder were dissolved in 
3 mL of 1:1 mixture of acetonitrile containing 0.1% trifluoroacetic acid (TFA) and 0.1% TFA in 
high-pressure liquid chromatography (HPLC)-grade water which were later used as HPLC 
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solvent mobile phase A and B, respectively. The resulting preparation was injected (95 
µL/injection) into an Eclipse-C18 column (4.6 × 150 mm) and the flow rate was set at 1 
mL/minute.  The HPLC gradient included a linear increase from 10% to 95% of mobile phase B 
in 10 minutes, and a constant condition of 95% B in 2 minutes. Mobile phase B was returned to 
10% in 1 minute and then held for 6 minutes to allow the column re-equilibration process. The 
detector was set at a wavelength of 210 nm. Under this condition, hexylcitric acid and its 
anhydride were co-eluted at 6.9 minute. The collected fraction, from 6.6 minute to 7.1 minute, 
was extracted with EtOAc and concentrated to yield 20 mg of yellow syrup. For NMR analysis 
the syrup was dissolved in dimethyl sulphoxide-d6.  All NMR spectra were recorded with a 
Varian VNMRS-500 MHz (Department of Chemistry and Biochemistry, Concordia University, 

















Results   
3.1 Secondary metabolite genes and gene clusters in A. niger NRRL3 genome.   
3.1.1 Secondary metabolite backbone genes and clusters defined for A. niger NRRL3.   
 
Bioinformatics analysis of the A. niger NRRL3 genome revealed a total of 96 secondary 








Table 4. Secondary metabolite clusters of A. niger NRRL3 and A. niger CBS 513.88.  
Secondary metabolite gene cluster NRRL 3 CBS 513.88 Description 
Domain(s) of backbone 
enzymes 
Azanigerone cluster NRRL3_00140 An09g01790 esterase/lipase AzaC 
 
Azanigerone cluster NRRL3_00141 An09g01800 acyltransferase AzaD 
 
Azanigerone cluster NRRL3_00142 An09g01810 ketoreductase AzaE 
 
Azanigerone cluster NRRL3_00143 An09g01820 AMP-dependent CoA ligase AzaF 
 




 An09g01840 salicylate monooxygenase AzaH 
 
Azanigerone cluster NRRL3_00146 An09g01850 cytochrome P450 AzaI 
 
Azanigerone cluster NRRL3_00147 An09g01860 polyketide synthase AzaA SAT-KS-AT-ACP-MT-KR 
Azanigerone cluster NRRL3_00148
a
 An09g01870 fungal-specific transcription factor AzaR 
 
Azanigerone cluster NRRL3_00149 An09g01880 zinc-type alcohol dehydrogenase AzaJ 
 
Azanigerone cluster NRRL3_00150 An09g01900 haem-degrading HbpS-like protein 
 
Azanigerone cluster NRRL3_00151 An09g01910 MFS-type efflux transporter AzaK 
 




 An09g01930 polyketide synthase AzaB 
KS-AT-DH-MT-KR-ER-KR-
ACP 
Carlosic acid and agglomerin cluster NRRL3_11025 An08g03730 oxoglutarate/iron-dependent dioxygenase CaaD 
 
Carlosic acid and agglomerin cluster NRRL3_11026 An08g03740 trans enoylreductase CaaB 
 
Carlosic acid and agglomerin cluster NRRL3_11027 An08g03750 major facilitator superfamily protein 
 
Carlosic acid and agglomerin cluster NRRL3_11028 An08g03760 SnoaL-like domain-containing protein 
 
Carlosic acid and agglomerin cluster NRRL3_11029
a
 An08g03770 fungal-specific transcription factor CaaR 
 
Carlosic acid and agglomerin cluster NRRL3_11030 An08g03780 cytochrome P450 CaaC 
 
Carlosic acid and agglomerin cluster NRRL3_11031 An08g03790 




Conidial pigmentation gene NRRL3_00462
a
 An09g05730 polyketide synthase AlbA/FwnA SAT-KS-AT-PT-ACP-ACP-Te 
Conidial pigmentation gene NRRL3_01039
a
 An14g05350 hydrolase AygA/OlvA 
 
Conidial pigmentation gene NRRL3_01040
a
 An14g05370 multicopper oxidase BrnA 
 
Conidial pigmentation gene NRRL3_02783
a




Fumonisin cluster NRRL3_02178 An01g06820 bifunctional P-450:NADPH-P450 reductase Fum6 
 
Fumonisin cluster NRRL3_02179 An01g06830 short-chain dehydrogenase/reductase family protein 
 
Fumonisin cluster NRRL3_02180 An01g06840 AMP-dependent synthetase/ligase Fum10 
 
Fumonisin cluster NRRL3_02181 An01g06850 iron-containing alcohol dehydrogenase Fum7 
 
Fumonisin cluster NRRL3_02182 An01g06860 phytanoyl-CoA dioxygenase Fum9 
 
Fumonisin cluster NRRL3_02183 An01g06870 aminotransferase, class I/class II Fum8 
 
Fumonisin cluster NRRL3_02184 An01g06880 NAD-dependent epimerase/dehydratase family protein Fum13 
 
Fumonisin cluster NRRL3_02185 An01g06890 non-ribosomal peptide synthetase-like protein Fum14 T-C 
Fumonisin cluster NRRL3_02186 An01g06900 fungal-specific transcription factor Fum21 
 
Fumonisin cluster NRRL3_02187 An01g06910 cytochrome P450 Fum15 
 
Fumonisin cluster NRRL3_02188 An01g06920 ABC transporter Fum19 
 
Fumonisin cluster NRRL3_02189 An01g06930 polyketide synthase Fum1 KS-AT-DH-MT-ER-KR-ACP 
Fumonisin cluster NRRL3_02190 An01g06940 major facilitator superfamily protein 
 
Kotanin cluster NRRL3_07482 An04g09570 major facilitator superfamily protein 
 
Kotanin cluster NRRL3_07483 An04g09560 cell wall mannoprotein 1-like protein 
 








 An04g09530 polyketide synthase KtnS SAT-KS-AT-PT-ACP 
Kotanin cluster NRRL3_07487
a
 An04g09520 O-methyltransferase KtnB 
 
NRRL3_00030 cluster NRRL3_00025 An09g00390 FAD-dependent oxidoreductase domain-containing protein 
 
NRRL3_00030 cluster NRRL3_00026 An09g00400 amino acid/polyamine transporter I family protein 
 
NRRL3_00030 cluster NRRL3_00027 An09g00420 HAD-like domain-containing protein 
 
NRRL3_00030 cluster NRRL3_00028 An09g00430 fungal-specific transcription factor 
 
NRRL3_00030 cluster NRRL3_00029 An09g00440 hypothetical protein 
 
NRRL3_00030 cluster NRRL3_00030 An09g00450 non-ribosomal peptide synthetase-like protein A-T-NADB 
NRRL3_00036 cluster NRRL3_00036 An09g00520 non-ribosomal peptide synthetase T-C-A-T-C-Rpt 
NRRL3_00036 cluster NRRL3_00037 An09g00530 FAD-binding domain-containing protein 
 
NRRL3_00036 cluster NRRL3_00038 An09g00540 hypothetical protein 
 
NRRL3_00036 cluster NRRL3_00039 An09g00550 major facilitator superfamily protein 
 
NRRL3_00036 cluster NRRL3_00040 An09g00560 cytochrome P450 family protein 
 
NRRL3_00036 cluster NRRL3_00041 An09g00570 NAD(P)-binding domain-containing protein 
 
NRRL3_00036 cluster NRRL3_00042 An09g00580 fungal-specific transcription factor 
 




NRRL3_00036 cluster NRRL3_00044 An09g00600 NmrA-like family protein 
 
NRRL3_00036 cluster NRRL3_00046 NFG hypothetical protein 
 
NRRL3_00036 cluster NRRL3_00048 An09g00620 short-chain dehydrogenase/reductase family protein 
 
NRRL3_00102 cluster NRRL3_00099 An09g01260 fatty acyl-CoA reductase-like protein 
 
NRRL3_00102 cluster NRRL3_00100 An09g01270 cytochrome P450 
 
NRRL3_00102 cluster NRRL3_00101 An09g01280 cell wall mannoprotein 1-like protein 
 
NRRL3_00102 cluster NRRL3_00102 An09g01290 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_00102 cluster NRRL3_00103 An09g01300 
organic solute transporter subunit alpha/transmembrane protein 
184 family protein  
NRRL3_00102 cluster NRRL3_00104 An09g01310 fungal-specific transcription factor 
 
NRRL3_00102 cluster NRRL3_00105 An09g01320 FAD-binding domain-containing protein 
 
NRRL3_00102 cluster NRRL3_00106 An09g01330 squalene cyclase family protein 
 
NRRL3_00102 cluster NRRL3_00107 An09g01340 cytochrome P450 family protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00134 An09g01680 RTA-like protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00135 An09g01690 non-ribosomal peptide synthetase A-T-C-C-A-T-C 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00136 An09g01700 
ABC transporter type 1, transmembrane domain-containing 
protein  
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00137 An09g01710 alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00138 An09g01740 fatty acid synthase beta subunit AT-ER-DH-MPT 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00154 An09g01940 RTA-like protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00139 An09g01760 HotDog domain-containing protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00155 An09g01950 cytochrome P450 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00156 An09g01970 oxidoreductase domain-containing protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00157 An09g01990 branched-chain amino acid aminotransferase-like protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00158 An09g02000 cytochrome P450 family protein 
 
NRRL3_00135/NRRL3_00138/NRRL3_00159 cluster NRRL3_00159 An09g02010 fatty acid synthase alpha subunit MPT-ACP-KR-KS 
NRRL3_00166 cluster NRRL3_00166 An09g02100 polyketide synthase-like protein 
[KR-KS-AT-DH-ACP]-ACP-
MT-Te  
NRRL3_00166 cluster NRRL3_00167 An09g02120 isochorismatase family protein 
 
NRRL3_00166 cluster NRRL3_00168 An09g02150 FAD-binding domain-containing protein 
 
NRRL3_00204 cluster NRRL3_00202 An09g02580 major facilitator superfamily protein 
 
NRRL3_00204 cluster NRRL3_00203 An09g02590 cytochrome P450 
 
NRRL3_00204 cluster NRRL3_00204 An09g02610 sesquiterpene cyclase  Isoprenoid_Biosyn_C1 
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NRRL3_00204 cluster NRRL3_00205 An09g02620 fungal-specific transcription factor 
 
NRRL3_00410 cluster NRRL3_00405 An09g05050 gurmarin/antimicrobial peptide-like protein 
 
NRRL3_00410 cluster NRRL3_00406 An09g05060 fungal-specific transcription factor 
 
NRRL3_00410 cluster NRRL3_00407 An09g05070 major facilitator superfamily protein 
 
NRRL3_00410 cluster NRRL3_00408 An09g05080 aminotransferase class I and II family protein 
 
NRRL3_00410 cluster NRRL3_00409 An09g05100 impact family protein 
 
NRRL3_00410 cluster NRRL3_00410 An09g05110 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_00410 cluster NRRL3_00411 An09g05120 carboxylesterase family protein 
 
NRRL3_00410 cluster NRRL3_00412 An09g05130 catechol oxidase 
 
NRRL3_00410 cluster NRRL3_00413 An09g05140 NmrA-like family protein 
 
NRRL3_00410 cluster NRRL3_00414 An09g05150 
intradiol ring-cleavage dioxygenase core domain-containing 
protein  
NRRL3_00430 cluster NRRL3_00430 An09g05340 polyketide synthase KS-AT-DH-ER-KR-ACP 
NRRL3_00430 cluster NRRL3_00431 An09g05350 tannase/feruloyl esterase family protein 
 
NRRL3_00755 cluster NRRL3_00755 An14g01910 hybrid polyketide synthase/non-ribosomal peptide synthetase 
KS-AT-DH-MT-KR-ACP--C-
Rpt-A-(T) 
NRRL3_00755 cluster NRRL3_00756 An14g01940 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_00755 cluster NRRL3_00757 An14g01950 alcohol acetyltransferase/N-acetyltransferase family protein 
 
NRRL3_00755 cluster NRRL3_00758 An14g01960 anoctamin-like protein 
 
NRRL3_00998 cluster NRRL3_00997 An14g04840 methyltransferase VrtF-like protein 
 
NRRL3_00998 cluster NRRL3_00998 An14g04850 hybrid polyketide synthase/non-ribosomal peptide synthetase A-T--KS-AT-KR-ACP 
NRRL3_01334 cluster NRRL3_01332 An13g03060 CDR ABC transporter domain-containing protein 
 
NRRL3_01334 cluster NRRL3_01333.1 An13g03050 hypothetical protein 
 
NRRL3_01334 cluster NRRL3_01334 An13g03040 non-ribosomal peptide synthetase C-Rpt-A-T-C 
NRRL3_01334 cluster NRRL3_01335 An13g03030 fungal-specific transcription factor 
 
NRRL3_01339 cluster NRRL3_01336 An13g03000 cytochrome P450 
 
NRRL3_01339 cluster NRRL3_01337 An13g02990 hypothetical protein 
 
NRRL3_01339 cluster NRRL3_01338 An13g02980 calycin domain-containing protein 
 
NRRL3_01339 cluster NRRL3_01339 An13g02960 hybrid polyketide synthase/non-ribosomal peptide synthetase 
KS-AT-(DH-MT-KR-ACP--C-
Rpt-A-T-Te) 
NRRL3_01339 cluster NRRL3_01340 An13g02940 enoyl reductase  
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01366 An13g02480 flavin amine oxidase family protein 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01367 An13g02460 non-ribosomal peptide synthetase-like protein A-T-Te 
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NRRL3_01367/NRRL3_01369 cluster NRRL3_01368 An13g02450 six-hairpin glycosidase-like protein 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01369 An13g02430 polyketide synthase KS-AT-DH-ER-KR-ACP 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01370 An13g02420 serine hydrolase FSH family protein 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01371 An13g02410 magnesium transporter CorA/zinc transporter ZntB family protein 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01372 An13g02400 fungal-specific transcription factor 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01373 An13g02390 purine permease 
 
NRRL3_01367/NRRL3_01369 cluster NRRL3_01374 NFG polyamine transporter 
 
NRRL3_01418 cluster NRRL3_01414 An13g01890 
S-adenosyl-L-methionine dependent methyltransferase domain-
containing protein  





NRRL3_01418 cluster NRRL3_01416 An13g01870 hypothetical protein 
 
NRRL3_01418 cluster NRRL3_01417 An13g01860 amino acid/polyamine transporter I family protein 
 
NRRL3_01418 cluster NRRL3_01418 An13g01840 4-dimethylallyltryptophan synthase PT-DMATS_CynD 
NRRL3_01804 cluster NRRL3_01804 An01g02030  polyketide synthase (KS-AT-DH)-MT-ER-KR-ACP 
NRRL3_01804 cluster NRRL3_01805 NFG fatty acyl-CoA reductase-like protein 
 
NRRL3_01804 cluster NRRL3_01806 partially NFG hypothetical protein 
 
NRRL3_01804 cluster NRRL3_01807 An01g02040 chloramphenicol acetyltransferase-like protein 
 
NRRL3_01804 cluster NRRL3_01808 An01g02050 fungal-specific transcription factor 
 
NRRL3_01804 cluster NRRL3_01809 An01g02060 major facilitator superfamily protein 
 
NRRL3_02191 cluster NRRL3_02191 An01g06950 polyketide synthase KS-AT-DH-KR-ER-KR-ACP 
NRRL3_02191 cluster NRRL3_02192 An01g06960 HAD hydrolase subfamily IA protein 
 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02592 An01g11760 major facilitator superfamily protein 
 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02593 An01g11770 non-ribosomal peptide synthetase-like protein A-T 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02594 NFG tyrosinase copper-binding domain-containing protein 
 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02595 An01g11780 NUDIX hydrolase domain-containing protein 
 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02596 An01g11790 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_02593/NRRL3_02596 cluster NRRL3_02597 An01g11800 FAD-binding domain-containing protein 
 
NRRL3_02620/NRRL3_02621 cluster NRRL3_02619 An01g12020 glycosyltransferase family 2 protein 
 
NRRL3_02620/NRRL3_02621 cluster NRRL3_02620 An01g12030 acyl carrier protein ACP 
NRRL3_02620/NRRL3_02621 cluster NRRL3_02621 An01g12040 polyketide synthase-like protein KR-ACP 
NRRL3_02852 cluster NRRL3_02844 An01g14760 FAD-binding domain-containing protein 
 




NRRL3_02852 cluster NRRL3_02846 An01g14780 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_02852 cluster NRRL3_02847 An01g14790 maltose/galactoside acetyltransferase domain-containing protein 
 
NRRL3_02852 cluster NRRL3_02848 An01g14800 tannase/feruloyl esterase family protein 
 
NRRL3_02852 cluster NRRL3_02849 An01g14810 hypothetical protein 
 
NRRL3_02852 cluster NRRL3_02850 An01g14820 hypothetical protein 
 
NRRL3_02852 cluster NRRL3_02851 An01g14840 alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_02852 cluster NRRL3_02852 An01g14850 non-ribosomal peptide synthetase-like protein A-T-(NADB-AAA) 
NRRL3_02852 cluster NRRL3_02853 An01g14870 hypothetical protein 
 
NRRL3_02852 cluster NRRL3_02854 An01g14880 alcohol dehydrogenase [NADP(+)] 
 
NRRL3_02852 cluster NRRL3_02855 An01g14890 kynurenine formamidase-like protein 
 
NRRL3_02852 cluster NRRL3_02856 An01g14900 major facilitator superfamily protein 
 
NRRL3_02852 cluster NRRL3_02857 An01g14910 fungal-specific transcription factor 
 
NRRL3_02852 cluster NRRL3_02858 An01g14920 peptidase M24 domain-containing protein 
 
NRRL3_02852 cluster NRRL3_02859 An01g14930 major facilitator sugar transporter-like family protein 
 
NRRL3_02887 cluster NRRL3_02887 An12g10860 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_02887 cluster NRRL3_02888 An12g10850 HpcH/HpaI aldolase/citrate lyase domain-containing protein 
 
NRRL3_02887 cluster NRRL3_02889 An12g10840 hypothetical protein 
 
NRRL3_02887 cluster NRRL3_02890 An12g10830 RmlC-like cupin domain-containing protein 
 
NRRL3_02887 cluster NRRL3_02891 An12g10810 hypothetical protein 
 
NRRL3_02887 cluster NRRL3_02892 An12g10790 chloroperoxidase domain-containing protein 
 
NRRL3_02961.1 cluster NRRL3_02955 An12g10150 YjgF/YER057c/UK114 family protein 
 
NRRL3_02961.1 cluster NRRL3_02956 An12g10140 hydroxyacid oxidase 
 
NRRL3_02961.1 cluster NRRL3_02957 An12g10130 amino acid/polyamine transporter I family protein 
 
NRRL3_02961.1 cluster NRRL3_02958 An12g10120 class II aldolase/adducin family protein 
 
NRRL3_02961.1 cluster NRRL3_02959 An12g10110 fungal-specific transcription factor 
 
NRRL3_02961.1 cluster NRRL3_02960 An12g10100 ketopantoate reductase ApbA/PANE-like protein 
 
NRRL3_02961.1 cluster NRRL3_02961.1 An12g10090 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_02961.1 cluster NRRL3_02962 An12g10080 uncharacterized protein 
 
NRRL3_02961.1 cluster NRRL3_02963 An12g10060 short-chain dehydrogenase/reductase family protein 
 
NRRL3_02961.1 cluster NRRL3_02964 An12g10050 amidohydrolase-related domain-containing protein 
 
NRRL3_03167 cluster NRRL3_03164 An12g07260 alpha/beta hydrolase fold-1 domain-containing protein 
 




NRRL3_03167 cluster NRRL3_03166 An12g07240 
P-loop containing nucleoside triphosphate hydrolase domain-
containing protein  
NRRL3_03167 cluster NRRL3_03167 An12g07230 non-ribosomal peptide synthetase 
A-T-C-Rpt-A-MT-A-T-C-A-T-
Te 
NRRL3_03167 cluster NRRL3_03168 not called hypothetical protein 
 
NRRL3_03167 cluster NRRL3_03169 An12g07220 NAD(P)-binding domain-containing protein 
 
NRRL3_03167 cluster NRRL3_03170 An12g07200 hypothetical protein 
 
NRRL3_03167 cluster NRRL3_03171 An12g07290 fungal-specific transcription factor 
 
NRRL3_03167 cluster NRRL3_03172 An12g07280 alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_03184 cluster NRRL3_03180 An12g07110 salicylate synthase-like protein 
 
NRRL3_03184 cluster NRRL3_03181 not called alkyl-hydroperoxide reductase D-like protein 
 
NRRL3_03184 cluster NRRL3_03182 An12g07100 hypothetical protein 
 
NRRL3_03184 cluster NRRL3_03183 An12g07090 FAD-binding domain-containing protein 
 
NRRL3_03184 cluster NRRL3_03184 An12g07070 polyketide synthase KS-AT-DH-ER-KR-ACP 
NRRL3_03184 cluster NRRL3_03185 An12g07060 serine hydrolase FSH family protein 
 
NRRL3_03756 cluster NRRL3_03750 An15g02070 FAD-binding domain-containing protein 
 
NRRL3_03756 cluster NRRL3_03751 An15g02080 fungal-specific transcription factor 
 
NRRL3_03756 cluster NRRL3_03752 not called carbohydrate-binding module family 16 protein 
 
NRRL3_03756 cluster NRRL3_03753 An15g02090 hypothetical protein 
 
NRRL3_03756 cluster NRRL3_03754 An15g02110 tannase/feruloyl esterase family protein 
 
NRRL3_03756 cluster NRRL3_03755 An15g02120 two-component system protein 
 
NRRL3_03756 cluster NRRL3_03756 An15g02130 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_03756 cluster NRRL3_03757 An15g02140 serine hydrolase FSH family protein 
 
NRRL3_03756 cluster NRRL3_03758 An15g02150 hypothetical protein 
 
NRRL3_03756 cluster NRRL3_03759 An15g02160 carboxymuconolactone decarboxylase-like protein 
 
NRRL3_03756 cluster NRRL3_03760 An15g02180 FAD-binding domain-containing protein 
 
NRRL3_03756 cluster NRRL3_03761 An15g02190 major facilitator superfamily protein 
 
NRRL3_03756 cluster NRRL3_03762 An15g02200 GMC oxidoreductase 
 
NRRL3_03756 cluster NRRL3_03762 An15g02200 GMC oxidoreductase 
 
NRRL3_03891 cluster NRRL3_03891 An15g04140 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_03891 cluster NRRL3_03892 An15g04150 short-chain dehydrogenase/reductase family protein 
 
NRRL3_03891 cluster NRRL3_03893 
An15g04160 
An15g04170 




NRRL3_03891 cluster NRRL3_03894 An15g04180 cytochrome P450 family protein 
 
NRRL3_03891 cluster NRRL3_03895 An15g04190 hypothetical protein 
 
NRRL3_03891 cluster NRRL3_03896 An15g04200 hypothetical protein 
 
NRRL3_03891 cluster NRRL3_03897 An15g04210 aldo/keto reductase/potassium channel subunit beta family protein 
 
NRRL3_03891 cluster NRRL3_03898 An15g04220 fungal-specific transcription factor 
 
NRRL3_03977 cluster NRRL3_03972 An15g05040 beta-lactamase-related protein 
 
NRRL3_03977 cluster NRRL3_03973 An15g05050 nucleoside phosphorylase family protein 
 
NRRL3_03977 cluster NRRL3_03974 An15g05060 major facilitator superfamily protein 
 
NRRL3_03977 cluster NRRL3_03975 An15g05070 cytochrome P450 family protein 
 
NRRL3_03977 cluster NRRL3_03976 An15g05080 fungal-specific transcription factor 
 
NRRL3_03977 cluster NRRL3_03977 An15g05090 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_03977 cluster NRRL3_03978 An15g05100 fungal-specific transcription factor 
 
NRRL3_03977 cluster NRRL3_03979 An15g05110 cytochrome P450 
 
NRRL3_04180 cluster NRRL3_04173 An15g07460 oligopeptide transporter OPT superfamily protein 
 
NRRL3_04180 cluster NRRL3_04174 An15g07470 hypothetical protein 
 
NRRL3_04180 cluster NRRL3_04175 An15g07480 hypothetical protein 
 
NRRL3_04180 cluster NRRL3_04176 An15g07490 TauD/TfdA-like domain-containing protein 
 
NRRL3_04180 cluster NRRL3_04177 An15g07500 ribokinase/fructokinase family protein 
 
NRRL3_04180 cluster NRRL3_04178 An15g07510 proton-dependent oligopeptide transporter family protein 
 
NRRL3_04180 cluster NRRL3_04179 An15g07520 uncharacterized protein 
 
NRRL3_04180 cluster NRRL3_04180 An15g07530 non-ribosomal peptide synthetase 
A-T-C-A-T-C-A-T-C-A-T-C-
A-T-C 
NRRL3_04226 cluster NRRL3_04223 assembly issue 
alpha-hydroxy acid dehydrogenase family protein, FMN-
dependent  
NRRL3_04226 cluster NRRL3_04224 assembly issue hypothetical protein 
 
NRRL3_04226 cluster NRRL3_04225 assembly issue flavin monooxygenase-like protein 
 
NRRL3_04226 cluster NRRL3_04226 assembly issue hybrid polyketide synthase/non-ribosomal peptide synthetase 
KS-AT-DH-KR-ACP--C-A-T-
Te 
NRRL3_04226 cluster NRRL3_04227 An07g00010 EthD domain-containing protein 
 
NRRL3_04226 cluster NRRL3_04228 An07g00020 alpha/beta hydrolase fold-5 domain-containing protein 
 
NRRL3_04226 cluster NRRL3_04229 An07g00030 aldo/keto reductase/potassium channel subunit beta family protein 
 
NRRL3_04226 cluster NRRL3_04230 An07g00040 AMP-dependent synthetase/ligase domain-containing protein 
 




NRRL3_04226 cluster NRRL3_04232 An07g00060 major facilitator superfamily protein 
 
NRRL3_04226 cluster NRRL3_04233 An07g00070 EthD domain-containing protein 
 
NRRL3_04226 cluster NRRL3_04234 An07g00080 cytochrome P450 
 
NRRL3_04226 cluster NRRL3_04235 An07g00090 amidohydrolase-related domain-containing protein 
 
NRRL3_04226 cluster NRRL3_04236 An07g00100 amidase family protein 
 
NRRL3_04226 cluster NRRL3_04237 An07g00110 beta-lactamase-related protein 
 
NRRL3_04226 cluster NRRL3_04238 An07g00130 GNAT domain-containing protein 
 
NRRL3_04226 cluster NRRL3_04239 An07g00150 major facilitator superfamily protein 
 
NRRL3_04226 cluster NRRL3_04240 An07g00170 hypothetical protein 
 
NRRL3_04226 cluster NRRL3_04241 An07g00190 
S-adenosyl-L-methionine dependent methyltransferase domain-
containing protein  
NRRL3_04226 cluster NRRL3_04242 An07g00200 alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_04305 cluster NRRL3_04305 An07g01030 polyketide synthase KS-AT-DH-(ACP) 
NRRL3_04420 cluster NRRL3_04419 An07g02550 cytochrome P450 family protein 
 
NRRL3_04420 cluster NRRL3_04420 An07g02560 4-dimethylallyltryptophan synthase PT-DMATS_CynD 
NRRL3_04420 cluster NRRL3_04421 An07g02540 MFS-type short-chain carboxylic acid transporter 
 
NRRL3_05440 cluster NRRL3_05437 An02g10170 major facilitator superfamily protein 
 
NRRL3_05440 cluster NRRL3_05438 An02g10160 aminotransferase class I and II family protein 
 
NRRL3_05440 cluster NRRL3_05439 An02g10150 CoA-transferase family III protein 
 
NRRL3_05440 cluster NRRL3_05440 An02g10140 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_05440 cluster NRRL3_05441 NFG fungal-specific transcription factor 
 
NRRL3_05484 cluster NRRL3_05484 An02g09430 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_05484 cluster NRRL3_05485 An02g09420 cytochrome P450 family protein 
 
NRRL3_05588 cluster NRRL3_05580 An02g08370 flavin amine oxidase family protein 
 
NRRL3_05588 cluster NRRL3_05581 An02g08360 RmlC-like cupin domain-containing protein 
 
NRRL3_05588 cluster NRRL3_05582 An02g08350 fungal-specific transcription factor 
 
NRRL3_05588 cluster NRRL3_05583 An02g08340 amino acid/polyamine transporter I family protein 
 
NRRL3_05588 cluster NRRL3_05584 An02g08330 major facilitator superfamily protein 
 
NRRL3_05588 cluster NRRL3_05585 An02g08320 hypothetical protein 
 
NRRL3_05588 cluster NRRL3_05586 An02g08310 enoyl reductase  
 
NRRL3_05588 cluster NRRL3_05587 An02g08300 EthD domain-containing protein 
 





NRRL3_05848 cluster NRRL3_05846 An02g05090 cytochrome P450 family protein 
 
NRRL3_05848 cluster NRRL3_05847 An02g05080 FAD-binding domain-containing protein 
 
NRRL3_05848 cluster NRRL3_05848 An02g05070 non-ribosomal peptide synthetase A-T-C-T-C 
NRRL3_06189 cluster NRRL3_06189 An02g00840 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_06189 cluster NRRL3_06190 An02g00810 COMT-type O-methyltransferase family protein 
 
NRRL3_06189 cluster NRRL3_06191 An02g00800 hypothetical protein 
 
NRRL3_06189 cluster NRRL3_06192 An02g00790 hypothetical protein 
 
NRRL3_06189 cluster NRRL3_06193 An02g00780 alpha/beta hydrolase fold domain-containing protein 
 
NRRL3_06189 cluster NRRL3_06194 An02g00760 major facilitator superfamily protein 
 
NRRL3_06189 cluster NRRL3_06195 An02g00750 hypothetical protein 
 
NRRL3_06189 cluster NRRL3_06196 An02g00740 FAD-binding domain-containing protein 
 
NRRL3_06217 cluster NRRL3_06216 An02g00460 FAD-binding domain-containing protein 
 
NRRL3_06217 cluster NRRL3_06217 An02g00450 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_06217 cluster NRRL3_06218 An02g00440 serine hydrolase FSH family protein 
 
NRRL3_06217 cluster NRRL3_06219 An02g00420 major facilitator superfamily protein 
 
NRRL3_06237 cluster NRRL3_06224 An02g00340 amidase family protein 
 
NRRL3_06237 cluster NRRL3_06225 An02g00330 hypothetical protein 
 
NRRL3_06237 cluster NRRL3_06226 An02g00320 hypothetical protein 
 
NRRL3_06237 cluster NRRL3_06227 An02g00310 aldo-keto reductase family protein 
 
NRRL3_06237 cluster NRRL3_06228 An02g00300 dienelactone hydrolase domain-containing protein 
 
NRRL3_06237 cluster NRRL3_06229 An02g00290 fungal-specific transcription factor 
 
NRRL3_06237 cluster NRRL3_06230 An02g00280 major facilitator superfamily domain-containing protein 
 
NRRL3_06237 cluster NRRL3_06231 An02g00270 RmlC-like cupin domain-containing protein 
 
NRRL3_06237 cluster NRRL3_06232 An02g00260 fungal-specific transcription factor 
 
NRRL3_06237 cluster NRRL3_06233 An02g00250 deoxyribose-phosphate aldolase 
 
NRRL3_06237 cluster NRRL3_06234 An02g00240 amino acid/polyamine transporter I family protein 
 
NRRL3_06237 cluster NRRL3_06235 An02g00230 phytanoyl-CoA dioxygenase family protein 
 
NRRL3_06237 cluster NRRL3_06236 An02g00220 short-chain dehydrogenase/reductase family protein 
 
NRRL3_06237 cluster NRRL3_06237 An02g00210 non-ribosomal peptide synthetase-like protein A-T-Dhe 
NRRL3_06237 cluster NRRL3_06238 An02g00200 hypothetical protein 
 
NRRL3_06237 cluster NRRL3_06239 An02g00190 amidase family protein 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06340 An10g00630 fatty acid synthase alpha subunit MPT-ACP-KR-KS 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06341 An10g00650 fatty acid synthase beta subunit AT-ER-DH-MPT 
49 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06342 An10g00660 cytochrome P450 family protein 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06343 An10g00670 methyltransferase type 11 domain-containing protein 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06344 An10g00680 ATPase, V0 complex, proteolipid subunit c 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06345 An10g00690 major facilitator superfamily protein 
 
NRRL3_06340/NRRL3_06341 cluster NRRL3_06346 An10g00700 drug resistance protein 
 
NRRL3_06432 cluster NRRL3_06431 An17g00440 cytochrome P450 family protein 
 
NRRL3_06432 cluster NRRL3_06432 An17g00450 sesquiterpene cyclase Isoprenoid_Biosyn_C1 
NRRL3_06801 cluster NRRL3_06796 NFG aminoglycoside phosphotransferase domain-containing protein 
 
NRRL3_06801 cluster NRRL3_06797 NFG RTA-like protein 
 
NRRL3_06801 cluster NRRL3_06798 NFG RTA-like protein 
 
NRRL3_06801 cluster NRRL3_06799 An16g06750 beta-lactamase-related protein 
 
NRRL3_06801 cluster NRRL3_06800 An16g06740 
ABC transporter type 1, transmembrane domain-containing 
protein  
NRRL3_06801 cluster NRRL3_06801 An16g06720 non-ribosomal peptide synthetase 
A-C-T-MT-A-T-C-A-T-C-A-T-
C-A-T-C 
NRRL3_07380 cluster NRRL3_07368 An16g00750 fungal-specific transcription factor 
 
NRRL3_07380 cluster NRRL3_07369 An16g00740 NmrA-like family protein 
 
NRRL3_07380 cluster NRRL3_07370 An16g00730 major facilitator superfamily protein 
 
NRRL3_07380 cluster NRRL3_07371 An16g00720 major facilitator superfamily protein 
 
NRRL3_07380 cluster NRRL3_07372 An16g00710 caleosin-related protein 
 
NRRL3_07380 cluster NRRL3_07373 An16g00700 FAD-dependent oxidoreductase domain-containing protein 
 
NRRL3_07380 cluster NRRL3_07374 An16g00680 RTA-like protein 
 
NRRL3_07380 cluster NRRL3_07375 An16g00670 hypothetical protein 
 
NRRL3_07380 cluster NRRL3_07376 An16g00660 NAD(P)-binding domain-containing protein 
 
NRRL3_07380 cluster NRRL3_07377 An16g00650 major facilitator superfamily protein 
 
NRRL3_07380 cluster NRRL3_07378 An16g00630 chloroperoxidase domain-containing protein 
 
NRRL3_07380 cluster NRRL3_07379 An16g00620 hypothetical protein 
 
NRRL3_07380 cluster NRRL3_07380 An16g00600 non-ribosomal peptide synthetase-like protein A-T-E 
NRRL3_07380 cluster NRRL3_07381 An16g00550 arylacetonitrilase NitAn 
 
NRRL3_07443 cluster NRRL3_07443 An04g10030 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_07443 cluster NRRL3_07444 An04g10020 serine hydrolase FSH family protein 
 
NRRL3_07443 cluster NRRL3_07445 An04g10010 hypothetical protein 
 




NRRL3_07443 cluster NRRL3_07447 An04g09990 short-chain dehydrogenase/reductase family protein 
 
NRRL3_07739 cluster NRRL3_07736 An04g06290 fungal-specific transcription factor 
 
NRRL3_07739 cluster NRRL3_07737 An04g06280 alkyl-hydroperoxide reductase D-like protein 
 
NRRL3_07739 cluster NRRL3_07738 An04g06270 methyltransferase domain-containing protein 
 
NRRL3_07739 cluster NRRL3_07739 An04g06260 non-ribosomal peptide synthetase A-T-C-A-T-C 
NRRL3_07739 cluster NRRL3_07740 An04g06250 major facilitator superfamily protein 
 
NRRL3_07739 cluster NRRL3_07741 An04g06240 fungal-specific transcription factor 
 
NRRL3_07812 cluster NRRL3_07810 An04g05440 xanthine dehydrogenase 
 
NRRL3_07812 cluster NRRL3_07811 An04g05430 hypothetical protein 
 
NRRL3_07812 cluster NRRL3_07812 An04g05420 non-ribosomal peptide synthetase-like protein A-T-NADB 
NRRL3_07812 cluster NRRL3_07813 An04g05410 hypothetical protein 
 
NRRL3_07812 cluster NRRL3_07814 An04g05380 versiconal hemiacetal acetate reductase 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07873 An04g04490 fungal-specific transcription factor 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07874 An04g04480 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07875 An04g04470 GNAT domain-containing protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07876 An04g04460 hypothetical protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07877 An04g04440 FAD-binding domain-containing protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07878 An04g04430 tannase/feruloyl esterase family protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07879 An04g04400 ankyrin repeat domain-containing protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07880 An04g04390 isochorismatase family protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07881 An04g04380 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07882 An04g04370 phenylalanine ammonia-lyase 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07883 An04g04360 thioesterase domain-containing protein 
 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07884 An04g04340 polyketide synthase KS-AT-DH-MT-KR-ACP 
NRRL3_07881/NRRL3_07884 cluster NRRL3_07885 An04g04330 AMP-dependent synthetase/ligase domain-containing protein 
 
NRRL3_08167 cluster NRRL3_08166 An04g01160 UbiB domain-containing protein 
 
NRRL3_08167 cluster NRRL3_08167 An04g01150 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_08167 cluster NRRL3_08168 An04g01140 aminotransferase, class I and II family protein 
 
NRRL3_08167 cluster NRRL3_08169 An04g01130 cytokinesis protein SepH 
 
NRRL3_08167 cluster NRRL3_08170 An04g01120 folylpolyglutamate synthetase-like protein 
 
NRRL3_08318 cluster NRRL3_08313 An03g06430 NADP-dependent alcohol dehydrogenase 
 
NRRL3_08318 cluster NRRL3_08314 An03g06420 GNAT domain-containing protein 
 




NRRL3_08318 cluster NRRL3_08316 An03g06400 fungal-specific transcription factor 
 
NRRL3_08318 cluster NRRL3_08317 An03g06390 FAD-binding domain-containing protein 
 
NRRL3_08318 cluster NRRL3_08318 An03g06380 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_08318 cluster NRRL3_08319 An03g06370 fungal-specific transcription factor 
 
NRRL3_08341 cluster NRRL3_08340 An03g06020 carboxymuconolactone decarboxylase-like protein 
 
NRRL3_08341 cluster NRRL3_08341 An03g06010 non-ribosomal peptide synthetase A-T-C-A-T-NADB 
NRRL3_08341 cluster NRRL3_08342 An03g06000 FAD-binding domain-containing protein 
 
NRRL3_08341 cluster NRRL3_08343 An03g05990 COMT-type O-methyltransferase family protein 
 
NRRL3_08341 cluster NRRL3_08344 An03g05980 fungal-specific transcription factor 
 
NRRL3_08341 cluster NRRL3_08345 An03g05960 epoxide hydrolase-like protein 
 
NRRL3_08341 cluster NRRL3_08346 An03g05950 major facilitator superfamily protein 
 
NRRL3_08369 cluster NRRL3_08368 An03g05690 ankyrin repeat domain-containing protein 
 
NRRL3_08369 cluster NRRL3_08369 An03g05680 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_08369 cluster NRRL3_08370 An03g05670 GMC oxidoreductase 
 
NRRL3_08369 cluster NRRL3_08371 An03g05660 catalase 
 
NRRL3_08369 cluster NRRL3_08372 An03g05650 fungal-specific transcription factor 
 
NRRL3_08388 cluster NRRL3_08381 An03g05500 fungal-specific transcription factor 
 
NRRL3_08388 cluster NRRL3_08382 An03g05490 iron-type alcohol dehydrogenase domain-containing protein 
 
NRRL3_08388 cluster NRRL3_08383 An03g05480 COMT-type O-methyltransferase family protein 
 
NRRL3_08388 cluster NRRL3_08384 An03g05470 RmlC-like cupin domain-containing protein 
 
NRRL3_08388 cluster NRRL3_08385 An03g05460 cytochrome P450 family protein 
 
NRRL3_08388 cluster NRRL3_08386 An03g05450 FAD-binding domain-containing protein 
 
NRRL3_08388 cluster NRRL3_08387 An03g05450 EthD domain-containing protein 
 
NRRL3_08388 cluster NRRL3_08388 An03g05440 polyketide synthase SAT-KS-AT-PT-ACP-ACP-Te 
NRRL3_08388 cluster NRRL3_08389 An03g05430 COMT-type O-methyltransferase family protein 
 
NRRL3_08411 cluster NRRL3_08411 An03g05140 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_08411 cluster NRRL3_08412 An03g05130 serine hydrolase FSH family protein 
 
NRRL3_08411 cluster NRRL3_08413 An03g05120 major facilitator superfamily protein 
 
NRRL3_08411 cluster NRRL3_08414 An03g05110 serine hydrolase FSH family protein 
 
NRRL3_08647 cluster NRRL3_08643 An03g01860 fungal-specific transcription factor 
 
NRRL3_08647 cluster NRRL3_08644 An03g01850 isochorismatase family protein 
 
NRRL3_08647 cluster NRRL3_08645 An03g01840 non-haem dioxygenase N-terminal domain-containing protein 
 




NRRL3_08647 cluster NRRL3_08647 An03g01820 polyketide synthase SAT-KS-AT-ACP-Te 
NRRL3_08647 cluster NRRL3_08648 An03g01810 serine hydrolase FSH family protein 
 
NRRL3_08647 cluster NRRL3_08649 An03g01800 acyl-CoA-binding protein 
 
NRRL3_08647 cluster NRRL3_08650 An03g01790 major facilitator superfamily protein 
 
NRRL3_08729 cluster NRRL3_08721 An03g00750 fungal-specific transcription factor 
 
NRRL3_08729 cluster NRRL3_08722 An03g00740 mannan endo-1,6-alpha-mannosidase 
 
NRRL3_08729 cluster NRRL3_08723 An03g00730 copper amine oxidase 
 
NRRL3_08729 cluster NRRL3_08724 An03g00720 hypothetical protein 
 
NRRL3_08729 cluster NRRL3_08725 An03g00690 hypothetical protein 
 
NRRL3_08729 cluster NRRL3_08726 An03g00680 major facilitator superfamily protein 
 
NRRL3_08729 cluster NRRL3_08727 An03g00670 opine dehydrogenase domain-containing protein 
 
NRRL3_08729 cluster NRRL3_08728 An03g00660 taurine dioxygenase 
 
NRRL3_08729 cluster NRRL3_08729 An03g00650 non-ribosomal peptide synthetase A-T-C-A-T-C 
NRRL3_08729 cluster NRRL3_08730 An03g00640 
amino acid transporter, transmembrane domain-containing 
protein BrsA-25  
NRRL3_08732 cluster NRRL3_08732 An03g00590 sesquiterpene cyclase Isoprenoid_Biosyn_C1 
NRRL3_08732 cluster NRRL3_08733 An03g00580 cytochrome P450 family protein 
 
NRRL3_08732 cluster NRRL3_08734 An03g00560 hypothetical protein 
 
NRRL3_08732 cluster NRRL3_08735 An03g00550 hypothetical protein 
 
NRRL3_08732 cluster NRRL3_08736 An03g00530 FAD-binding domain-containing protein 
 
NRRL3_08775 cluster NRRL3_08768 An03g00180 cytochrome P450 family protein 
 
NRRL3_08775 cluster NRRL3_08769 An03g00170 major facilitator superfamily protein 
 
NRRL3_08775 cluster NRRL3_08770 An03g00160 fungal-specific transcription factor 
 
NRRL3_08775 cluster NRRL3_08771 An03g00150 hypothetical protein 
 
NRRL3_08775 cluster NRRL3_08772 An03g00140 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_08775 cluster NRRL3_08773 An03g00130 GMC oxidoreductase 
 
NRRL3_08775 cluster NRRL3_08774 NFG hypothetical protein 
 
NRRL3_08775 cluster NRRL3_08775 NFG polyketide synthase 
SAT-KS-AT-PT-ACP-ACP-
MT-Te 
NRRL3_08790 cluster NRRL3_08788 NFG alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_08790 cluster NRRL3_08789 NFG major facilitator superfamily protein 
 





NRRL3_08891 cluster NRRL3_08890 An05g01050 fungal-specific transcription factor 
 
NRRL3_08891 cluster NRRL3_08891 An05g01060 non-ribosomal peptide synthetase 
A-T-C-C-A-T-C-A-T-C-A-T-C-
C 
NRRL3_08891 cluster NRRL3_08892 An05g01070 RTA-like protein 
 
NRRL3_08891 cluster NRRL3_08893 An05g01080 ankyrin repeat domain-containing protein 
 
NRRL3_08891 cluster NRRL3_08894 not called HotDog domain-containing protein 
 
NRRL3_08891 cluster NRRL3_08895 An05g01100 branched-chain amino acid aminotransferase-like protein 
 
NRRL3_08891 cluster NRRL3_08896 An05g01110 
ABC transporter type 1, transmembrane domain-containing 
protein  
NRRL3_08891 cluster NRRL3_08897 An05g01120 cytochrome P450 family protein 
 
NRRL3_08969 cluster NRRL3_08964 An12g02890 aminotransferase class IV family protein 
 
NRRL3_08969 cluster NRRL3_08965.1 An12g02880 fungal-specific transcription factor 
 
NRRL3_08969 cluster NRRL3_08966 not called major facilitator superfamily protein 
 
NRRL3_08969 cluster NRRL3_08967 An12g02860 major facilitator superfamily protein 
 
NRRL3_08969 cluster NRRL3_08968 An12g02850 pyridine nucleotide-disulphide oxidoreductase family protein 
 
NRRL3_08969 cluster NRRL3_08969 An12g02840 non-ribosomal peptide synthetase A-T-C-A-T-C-A-T-C-C-A-T-C 
NRRL3_08969 cluster NRRL3_08970 An12g02830 methyltransferase domain-containing protein 
 
NRRL3_08969 cluster NRRL3_08971 An12g02820 major facilitator superfamily protein 
 
NRRL3_08969 cluster NRRL3_08972 An12g02810 COMT-type O-methyltransferase family protein 
 








S-adenosyl-L-methionine dependent methyltransferase domain-
containing protein  
NRRL3_08978/NRRL3_08980/NRRL3_08984.1 
cluster 
NRRL3_08980 An12g02730 polyketide synthase KS-AT-DH-ER-KR-ACP 
NRRL3_08978/NRRL3_08980/NRRL3_08984.1 
cluster 
NRRL3_08981 An12g02720 serine hydrolase FSH family protein 
 
NRRL3_08984.1 cluster NRRL3_08982 An12g02700 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase  
 
NRRL3_08984.1 cluster NRRL3_08983 An12g02680 hypothetical protein 
 
NRRL3_08984.1 cluster NRRL3_08984.1 An12g02670 polyketide synthase 
KS-AT-DH-MT-ER-KR-ACP-
Te 




NRRL3_08984.1 cluster NRRL3_08986 An12g02650 methyltransferase domain-containing protein 
 
NRRL3_08984.1 cluster NRRL3_08987 An12g02640 aldo-keto reductase  
 
NRRL3_08984.1 cluster NRRL3_08988 An12g02630 NmrA-like family protein 
 
NRRL3_08984.1 cluster NRRL3_08989 An12g02620 fungal-specific transcription factor 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09030 An12g02090 fungal-specific transcription factor 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09031 An12g02080 cytochrome P450 family protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09032 An12g02070 ribonuclease/ribotoxin domain-containing protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09033 An12g02060 uncharacterized protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09034 An12g02050 polyketide synthase SAT-KS-AT-ACP-MT-Te 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09035 An12g02040 fungal-specific transcription factor 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09036 An12g02020 transferase family protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09037 An12g02000 FAD-binding domain-containing protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09038 An12g01990 fatty acid synthase beta subunit AT-ER-DH-MPT 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09039 An12g01980 fatty acid synthase alpha subunit MPT-ACP-KR-KS-PPT 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09040 An12g01970 sensitivity to red light reduced SRR1 domain-containing protein 
 
NRRL3_09034/NRRL3_09038/NRRL3_09039 NRRL3_09041.1 An12g01960 major facilitator superfamily protein 
 
NRRL3_09351 cluster NRRL3_09351 An11g09720 polyketide synthase KS-AT-DH-MT-KR-ACP 
NRRL3_09351 cluster NRRL3_09352 An11g09710 AMP-dependent synthetase/ligase domain-containing protein 
 
NRRL3_09351 cluster NRRL3_09353 An11g09700 uroporphyrin-III C-methyltransferase 
 
NRRL3_09351 cluster NRRL3_09354 An11g09690 26S proteasome regulatory complex subunit Rpn5 
 
NRRL3_09351 cluster NRRL3_09355 An11g09680 serine hydrolase FSH family protein 
 
NRRL3_09616 cluster NRRL3_09616 An11g06460 hybrid polyketide synthase/non-ribosomal peptide synthetase 
KS-AT-DH-KR-ACP--C-A-T-
Te 
NRRL3_09616 cluster NRRL3_09617 An11g06450 EthD domain-containing protein 
 
NRRL3_09616 cluster NRRL3_09618 An11g06440 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_09616 cluster NRRL3_09619 An11g06430 hypothetical protein 
 
NRRL3_09616 cluster NRRL3_09620 An11g06420 major facilitator superfamily protein 
 
NRRL3_09686/NRRL3_09693 cluster NRRL3_09686 An11g05570 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_09686/NRRL3_09693 cluster NRRL3_09687 An11g05560 aminotransferase, class I and II family protein 
 
NRRL3_09686/NRRL3_09693 cluster NRRL3_09688 An11g05550 major facilitator superfamily protein 
 
NRRL3_09686/NRRL3_09693 cluster NRRL3_09689 not called fungal-specific transcription factor 
 
NRRL3_09686/NRRL3_09693 cluster NRRL3_09693 An11g05500 non-ribosomal peptide synthetase-like protein A-T-Te 




NRRL3_09789/NRRL3_09792 cluster NRRL3_09789 An11g04280 polyketide synthase KS-AT-DH-ER-KR-ACP 
NRRL3_09789/NRRL3_09792 cluster NRRL3_09790 An11g04270 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_09789/NRRL3_09792 cluster NRRL3_09791 An11g04260 serine hydrolase FSH family protein 
 
NRRL3_09789/NRRL3_09792 cluster NRRL3_09792 An11g04250 non-ribosomal peptide synthetase-like protein A-T-Te 
NRRL3_09789/NRRL3_09792 cluster NRRL3_09793 An11g04240 hypothetical protein 
 
NRRL3_09789/NRRL3_09792 cluster NRRL3_09794 An11g04220 cytochrome P450 
 
NRRL3_09827 cluster NRRL3_09824 An11g03950 alpha/beta hydrolase fold-1 domain-containing protein 
 
NRRL3_09827 cluster NRRL3_09825 An11g03940 cytochrome P450 family protein 
 
NRRL3_09827 cluster NRRL3_09826 An11g03930 serine hydrolase FSH family protein 
 
NRRL3_09827 cluster NRRL3_09827 An11g03920 polyketide synthase KS-AT-DH-MT-ER-KR-ACP 
NRRL3_09848 cluster NRRL3_09846 An11g03690 fungal-specific transcription factor 
 
NRRL3_09848 cluster NRRL3_09847 An11g03680 zinc-type alcohol dehydrogenase superfamily protein 
 
NRRL3_09848 cluster NRRL3_09848 An11g03670 polyketide synthase 
(KS-AT-DH-MT-ER-KR-
ACP)-Te 
NRRL3_10148 cluster NRRL3_10146 An11g00070 COMT-type O-methyltransferase family protein 
 
NRRL3_10148 cluster NRRL3_10147 An11g00060 hypothetical protein 
 
NRRL3_10148 cluster NRRL3_10148 An11g00050 non-ribosomal peptide synthetase 
A-T-T-C-Rpt-C-A-T-C-Rpt-
(A)[MT}-A-T-C 
NRRL3_10209 cluster NRRL3_10204 An18g00470 dienelactone hydrolase domain-containing protein 
 
NRRL3_10209 cluster NRRL3_10205 An18g00480 major facilitator superfamily protein 
 
NRRL3_10209 cluster NRRL3_10206 An18g00490 FAD-binding domain-containing protein 
 
NRRL3_10209 cluster NRRL3_10207 An18g00500 cytochrome P450 family protein 
 
NRRL3_10209 cluster NRRL3_10208 An18g00510 FAD-binding domain-containing protein 
 
NRRL3_10209 cluster NRRL3_10209 An18g00520 hybrid polyketide synthase/non-ribosomal peptide synthetase 
KS-AT-DH-KR-ER-KR-ACP--
C-Rpt-A-T-Te 
NRRL3_10375 cluster NRRL3_10368 An18g02650 major facilitator superfamily protein 
 
NRRL3_10375 cluster NRRL3_10369.1 NFG methyltransferase type 11 domain-containing protein 
 
NRRL3_10375 cluster NRRL3_10370 NFG fungal-specific transcription factor 
 
NRRL3_10375 cluster NRRL3_10371 NFG serine hydrolase FSH family protein 
 
NRRL3_10375 cluster NRRL3_10372 NFG aldose 1-/glucose-6-phosphate 1-epimerase family protein 
 
NRRL3_10375 cluster NRRL3_10373 NFG cytochrome P450 family protein 
 
NRRL3_10375 cluster NRRL3_10374 NFG enoyl reductase 
 
NRRL3_10375 cluster NRRL3_10375 NFG polyketide synthase KS-AT-DH-MT-KR-ACP 
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NRRL3_10375 cluster NRRL3_10376 An18g02680 cytochrome P450 family protein 
 
NRRL3_10375 cluster NRRL3_10377 An18g02690 multicopper oxidase Mco1I 
 
NRRL3_10375 cluster NRRL3_10378 An18g02700 cytochrome P450 family protein 
 
NRRL3_10375 cluster NRRL3_10379 An18g02710 
terpenoid cyclases/protein prenyltransferase alpha-alpha toroid 
domain-containing protein  
NRRL3_10375 cluster NRRL3_10380 An18g02720 glutathione S-transferase 
 
NRRL3_10375 cluster NRRL3_10381 An18g02730 hypothetical protein 
 
NRRL3_10375 cluster NRRL3_10382 An18g02740 cytochrome P450 family protein 
 
NRRL3_10375 cluster NRRL3_10383 An18g02750 
S-adenosyl-L-methionine dependent methyltransferase domain-
containing protein  
NRRL3_10375 cluster NRRL3_10384 An18g02752 alpha/beta hydrolase fold-5 domain-containing protein 
 
NRRL3_10912 cluster NRRL3_10911 An08g02290 polyamine transporter 
 
NRRL3_10912 cluster NRRL3_10912 An08g02310 non-ribosomal peptide synthetase 
A-T-C-C-A-C-A-T-C-A-T-C-
C-T-C-(T) 
NRRL3_11121 cluster NRRL3_11120 An08g04810 enolase superfamily protein 
 
NRRL3_11121 cluster NRRL3_11121 An08g04820 non-ribosomal peptide synthetase-like protein A-T-NADB 
NRRL3_11458 cluster NRRL3_11458 An08g09220 non-ribosomal peptide synthetase-like protein C-T 
NRRL3_11458 cluster NRRL3_11459 An08g09230 cytochrome P450 
 
NRRL3_11458 cluster NRRL3_11460 An08g09240 fungal-specific transcription factor 
 
NRRL3_11458 cluster NRRL3_11461 An08g09250 major facilitator superfamily protein 
 
NRRL3_11458 cluster NRRL3_11462 An08g09260 acetoacetyl-CoA synthetase 
 
NRRL3_11458 cluster NRRL3_11463 An08g09280 fumarylacetoacetate hydrolase family protein 
 
NRRL3_11726 cluster NRRL3_11725 An06g00460 carboxylesterase family protein 
 
NRRL3_11726 cluster NRRL3_11726 An06g00430 polyketide synthase, type III KS 
NRRL3_11726 cluster NRRL3_11727 NFG dihydrolipoamide succinyltransferase  
 
NRRL3_11726 cluster NRRL3_11728 An06g00390 2-oxoglutarate dehydrogenase, mitochondrial  
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11759 An08g10970 dienelactone hydrolase domain-containing protein 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11760 An08g10860 fungal-specific transcription factor 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11761 An08g10850 major facilitator superfamily protein 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11762 An08g10840 zinc finger domain-containing protein, RING/FYVE/PHD-type 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11763 An08g10930 fatty acid synthase alpha subunit MPT-ACP-KR-KS-PPT 




NRRL3_11763/NRRL3_11767 cluster NRRL3_11765 An08g10880 fungal-specific transcription factor 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11766 An08g10870 2-methylcitrate dehydratase 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11767 An08g10860 fatty acid synthase beta subunit AT-ER-DH-MPT 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11768 An08g10830 polyprenyl synthetase family protein 
 
NRRL3_11763/NRRL3_11767 cluster NRRL3_11769 An08g10820 aldehyde dehydrogenase 
 
Ochratoxin cluster NFG An15g07890 bAP-1 transcription factor 
 
Ochratoxin cluster NFG An15g07900 bcytochrome P450 
 
Ochratoxin cluster NFG An15g07910 bnon-ribosomal peptide synthetase 
 
Ochratoxin cluster NRRL3_07207 
An15g07920 
polyketide synthase-like protein 
[KS-AT-DH-MT-ER]-KR-
(ACP) 
Pyranonigrin E cluster NRRL3_10119 An11g00350 FAD-dependent oxidoreductase PynB 
 
Pyranonigrin E cluster NRRL3_10120 An11g00330 NAD(P)-binding protein PynE 
 
Pyranonigrin E cluster NRRL3_10121 An11g00320 thioesterase domain-containing protein 
 
Pyranonigrin E cluster NRRL3_10122 An11g00310 aspartic peptidase family protein 
 
Pyranonigrin E cluster NRRL3_10123 An11g00300 FAD-binding domain-containing protein 
 
Pyranonigrin E cluster NRRL3_10124
a
 An11g00290 fungal-specific transcription factor PynR 
 
Pyranonigrin E cluster NRRL3_10125 An11g00280 O-methyltransferase PynC 
 
Pyranonigrin E cluster NRRL3_10126 An11g00270 cytochrome P450 PynD 
 
Pyranonigrin E cluster NRRL3_10127 An11g00260 MFS-type transporter PynF 
 
Pyranonigrin E cluster NRRL3_10128 An11g00250 




Siderophore cluster NRRL3_08528 An03g03620 MFS-type transporter SitT 
 
Siderophore cluster NRRL3_08529 An03g03600 helicase C-terminal domain-containing protein 
 
Siderophore cluster NRRL3_08530 An03g03590 GNAT domain-containing protein 
 
Siderophore cluster NRRL3_08531 An03g03580 hypothetical protein 
 
Siderophore cluster NRRL3_08532 An03g03570 phospholipid methyltransferase-like protein 
 
Siderophore cluster NRRL3_08533 An03g03570 hypothetical protein 
 
Siderophore cluster NRRL3_08534 An03g03560 siderophore iron transporter 
 
Siderophore cluster NRRL3_08535 An03g03550 crotonase superfamily protein 
 
Siderophore cluster NRRL3_08536 An03g03540 hydroxyornithine transacylase SidF 
 
Siderophore cluster NRRL3_08537 An03g03530 alpha/beta hydrolase fold domain-containing protein 
 
Siderophore cluster NRRL3_08538 An03g03520 non-ribosomal peptide synthetase SidD A-T-C-A-T-C 




Siderophore cluster NRRL3_08540 An03g03500 tetratricopeptide-like helical domain-containing protein 
 
Siderophore cluster NRRL3_11644 An06g01320 mevalonyl-CoA ligase SidI 
 
Siderophore cluster NRRL3_11645 An06g01300 non-ribosomal peptide synthetase SidC A-T-C-A-T-C-A-T-C-T-C-T-C 
TAN-1612/BMS-192548 cluster NRRL3_09545
a
















 An11g07310 polyketide synthase AdaA SAT-KS-AT-PT-ACP 




 An10g00100 fungal-specific transcription factor YanR 
 
Yanuthones cluster NRRL3_06288 An10g00110 cytochrome P450 YanC 
 
Yanuthones cluster NRRL3_06289 An10g00120 decarboxylase YanB 
 




 An10g00140 6-methylsalicylic acid synthase YanA KS-AT-DH-KR-ACP 
Yanuthones cluster NRRL3_06292
a




 An10g00160 O-mevalon transferase YanI 
 
Yanuthones cluster NRRL3_06294 An10g00170 short-chain dehydrogenase/reductase YanD 
 








NRRL3_01579 and NRRL3_01580 share homology with FASs involved in primary metabolism and are not included in this table. 
2
Domains are written from the N-terminus to the C-terminus. Round brackets denote domains found in the NRRL 3 model but missing 
in the CBS 513.88  counterpart; domains unique to the CBS 513.88 model are in  square brackets .A.: adenylation domain, ACP: acyl-
carrier protein,  AT: acyl transferase, C: condensation domain, DH: dehydratase, Dhe: dehydrogenase, ER: enoyl reductase, KR: 
ketoreductase, KS: ketosynthase, MPT: malonyl/palmitoyl transferase, MT: methyltransferase, NADB: NAD+ binding protein, PT: 
product template, PPT: phosphopantetheine transferase, Rpt: HxxPF repeat, SAT: starter unit acyltransferase, T: thiolation domain, 
Te: thioesterase/thioreductase. 
3
Genes found in only one A. niger strain are lebelled NFG (Not Found in Genome). 
4Gene IDs labelled “not called” represent differences in annotated gene models between strains not DNA sequence. 
a
Gene/gene product has been experimentally characterized. The extent of the cluster is based on other means. 
b




A comparison of enzyme complement between A. niger, A. fumigatus, A. oryzae, and A. 
nidulans is shown in Table 5.  A survey of backbone enzymes in these species reveals that the 
PKS/PKS-like and NRPS/NRPS-like genes make up the majority of all annotated backbone 
genes.  The complement of NRPS and NRPS-like genes are also approximately equal in each of 
the four Aspergilli.  Within the PKS category the majority of the genes encode the highly 
reducing class except in A. fumigatus and A. oryzae which have equivalent amounts of non-
reducing and highly-reducing PKS genes.  Partially reducing PKSs represent the smallest 
proportion of the PKS class in all species. The FAS complement is equal across the Aspergilli (5 
or 6 FAS alpha and beta genes) with the exception of A. fumigatus which only has a single FAS 
alpha/beta gene pair.  In the case of DMAT genes, the A. niger strains appear to have 
approximately half the number observed in A. fumigatus, A. oryzae, and A. nidulans.  A number 
of backbone genes which we identified manually appear to have been missed by the SMURF and 
antiSMASH algorithms in the previous study annotating gene clusters in A. niger CBS 513.88 
[27].  Looking at just the multi-domain backbone genes we were able to identify an additional 
PKS (An12g02050/ NRRL3_09034) and four additional NRPS-like genes (An01g06890/ 
NRRL3_02185, An01g11790/ NRRL3_02596, An01g14850/ NRRL3_02852 and An04g05420/ 











Table 5. Comparison of the total number of secondary metabolite backbone genes among four 







513.88 A. fumigatus A. nidulans A. oryzae 
FAS alpha/beta 5 5 1 6 5 
HPN 8 7 1 1 2 
HNP 1 1 0 0 0 
NRPS 18 18 7 9 17 
NRPS-like 21 21 6 13 13 
Non reducing PKS 8 7 5 8 12 
Highly reducing PKS 22 25 3 13 9 
Partially reducing PKS 4 3 3 2 1 
6-MSAS 1 1 0 0 1 
PKS type III 1 1 1 2 5 
PKS-like 4 4 1 1 0 
Sesquiterpene cyclase 3 3 0 2 1 
DMAT 2 2 5 7 6 
Total 98 98 33 64 72 
      1The A. nidulans FASs comprised of 5 alpha subunits and 6 beta subunits. 
2
The A. niger strains contain one FAS alpha/beta  
(NRRL3_01579/NRRL3_01580) homologous to the FASs of primary metabolism. 
3
HNP enzyme represents a hybrid enzyme which contains an NRPS and PKS module in 
reverse order to HPNs 
 
 
3.1.2 Experimentally characterized clusters with orthologues in A. niger NRRL3 
 
A literature search for experimentally characterized SM clusters was carried out to look 
for experimentally verified clusters in other species which have orthologues in A. niger NRRL3 
or in other A. niger strains which have counterparts in NRRL3.  Our BLASTP queries revealed a 
total of 11 clusters in A. niger NRRL3 which have been assigned function based on 
experimentally determined secondary metabolite production in other fungal species and A. niger 
strains.  The experimentally determined clusters were previously shown to produce: the 
azanigerones (A. niger) [100], TAN-1612 and its tautomer BMS-192548 (A. niger) [102], 1,8-
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dihydroxynaphthalene (DHN) melanin and its pigment derivatives (in A. niger and A. fumigatus) 
[100, 105, 137], fumonisin (in Gibberella moniliformis) [122], ochratoxin (A. niger) [123], 
pyranonigrin (A. niger) [47], carlosic acid and agglomerin (A. niger) [99], the yanuthones (A.  
niger) [124], the kotanins (A. niger) [97], and  two NRPS clusters with some genes shown to be 
involved in siderophore production (A.  fumigatus) (Table 4) [138].  These experimentally 
defined clusters from other other fungal species and A. niger strains were nearly identical to the 
counterpart clusters in A.niger NRRL3 with respect to gene complement and arrangement.  The 
exceptions were the fumonisin, DHN melanin and ochratoxin clusters.  These clusters in A. niger 
NRRL3 either have their genes dispersed in the genome (DHN melanin) or lacked multiple genes 
previously annotated in other fungal species or A. niger strains (fumonisin and ochratoxin) [122, 
123, 139] (Table 4).  We also observed that one of these clusters, the azanigerone cluster, 
appears to be located within the FAS NRRL3_00135/NRRL3_00138/NRRL3_00156 cluster.  
The FAS cluster appears without the intervening azanigerone cluster in A. acidus.  Conversely, 
the asperfuranone cluster which is nearly identical to the azanigerone cluster [100] appears 




Figure 14. A. niger ATCC 1015 (top) synteny in A. acidus (bottom) showing sequence 
similarity between their FAS A/B clusters but not with the azanigerone cluster (A).  A. niger 
ATCC 1015 (top) azanigerone cluster synteny with the similar asperfuranone cluster in A. 
nidulans (bottom) but not with the FAS A/B cluster of A. niger ATCC 1015 (B).  Screenshot 
taken and from Sybil online application from aspGD website (See Materials and Methods).  
 
3.1.3 Aspergillus niger NRRL3 and CBS 513.88: a genomic comparison of secondary 
metabolism between fungal strains 
 
To examine differences between strains of A. niger, the annotated secondary metabolite 
backbone enzymes from the NRRL3 strain were compared to that of CBS 513.88 strain.  The 
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comparison revealed differences with respect to enzyme absence/presence, enzyme truncation 
(remnants) and tailoring enzyme complement between clusters (Table 4, 6).  Analysis of 
backbone enzymes revealed NRRL3 is missing three highly reducing PKS and one NRPS which 
are present in CBS 513.88.  The reverse analysis shows one each of an NRPS, a partially 
reducing PKS and non-reducing PKS are present in NRRL3 but missing in CBS 513.88.   
 
Table 6. Secondary metabolite cluster differences between A. niger strains NRRL3 and CBS 
513.88. 
 1NRRL3  1CBS 513.88  









































Listed are genes encoding backbone enzymes. 
2
Cluster of genes encoding a full backbone enzyme plus one or more tailoring enzymes. 
3





3.1.4 Backbone gene remnants in A. niger NRRL3 and CBS 513.88 
 
Among the all the backbone genes found in the NRRL3 and CBS 513.88 genomes, we 
also located five remnant backbone genes.  For simplicity only the remnant IDs are listed here; 
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the full PKS counterpart ID is omitted but can be found in Table 4 or Figure 15.  Two remnants 
were unique to NRRL3 (NRRL3_00166, NRRL3_04207), two were unique to CBS 513.88 
(An01g02030, An11g03670) and one remnant was common to both strains 
(NRRL3_02621/An01g12040).  The unique remnants from one A. niger strain matched to (by 
BLASTP) to a complete counterpart in the opposite strain (NRRL3 vs CBS 513.88) while the 
shared remnant between both strains matched (by BLASTp) to a complete counterpart in A. 
tubingensis (Figure 15). All backbone remnant genes are exclusively of the PKS-like category 
and correspond to the 3’ end of a complete PKS.   The NRPS-like enzymes do not appear to have 
larger, multi-domain counterparts in other fungal species apart from 
NRRL3_02593/An01g11790 which had a counterpart in A. brasiliensis (Aspbr1_0027433) 
containing one additional C-terminal C domain.   
The full PKS counterparts of the PKS-like enzymes are all highly reducing with the 
exception of NRRL3_00166 which corresponds to a PKS that contains an incongruous KR 
domain upstream of the KS domain (Table 4).  Furthermore, the majority (four out of five) 
remnants contained at least the ACP minimal domain (NRRL3_00166, NRRL3_04207, 
An01g02030 and NRRL3_02621/An01g12040).  Lastly, a cluster analysis of remnant enzymes 
revealed that in three out of five remnants only the backbone enzyme is missing while 
surrounding genes are retained (Figure 15 A, B, E).  In the other two remnant clusters, 
NRRL3_04207 and An01g02030, additional surrounding genes are missing that are present in 
the opposing A. niger strain containing the full highly reducing PKS (Figure 15 C and D). 
An additional search to find more remnant backbone genes in the NRRL3 strain was 
carried out using the peptide sequences of 114 genes containing single SM domains.  These 
genes were not identified by the initial backbone search however their single domains were 
annotated from InterProScan (manuscript in preparation) as belonging to one of the SM 
backbone multi-domain enzymes (PKS, NRPS or FAS).  Surmising that the single domain 
enzymes may themselves be remnants, I queried these enzymes by BLASTP against other fungal 
genomes from the AspGD website. The query consisted of sequences from the following 
domains:  1 PKS-KS, 1 PKS-AT, 20 PKS-KR, 36 PKS-ER, 2 PKS-ACP, 33 NRPS-A, 2 FAS-
PPT, and 17 FAS-ACP.   None of the single domain enzymes appeared to have a full PKS, 







Figure 15. Remnant PKS-like enzymes from A. niger NRRL3 and CBS 513.88 aligned with their 
full enzyme counterparts.   
 
3.2 Upregulation of defined clusters 
3.2.1 Expression of genes encoding clustered transcription factors 
 
Given that 43 of the 84 SM clusters appear to have at least one resident transcription 
factor, we sought to overexpress some of these transcription factors in A. niger in an effort to 
induce cluster expression.  We selected 35 transcription factors within or just outside 31 clusters 
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for overexpression.  These  included the transcription factors of three known SM clusters which 
we used as controls: fumonisin (NRRL3_02186) [122], BMS-192548/TAN-1612 
(NRRL3_09545) [102], and the azanigerones (NRRL3_00148) [100].  Both BMS-192548/TAN-
1612 and the azanigerones are also colored compounds which allowed for quick phenotypic 
assessment of SM production following growth of transformants on selective media [100, 102].    
Of all the overexpressed transcription factors, six (including the controls) stimulated the 
production of identifiable compounds (NRRL3_00148, NRRL3_00406, NRRL3_02186, 
NRRL3_07873, NRRL3_09545, and NRRL3_11765) and one (NRRL3_08781) appeared to 
stimulate the production of compounds which we could not identify (Figure 16).  The regulators 
of the malformins (NRRL3_07873), pyrophen (NRRL3_00406) and tensyuic acids/hexylitaconic 
acid (NRRL3_11765) (herein referred to cumulatively as alkyl citric acids) are to our knowledge 
currently unknown and potentially constitute a novel means of overexpression for these orphan 
compounds.   While the identity of the compounds generated from the overexpression of 
NRRL3_08781 is unknown, the transcription factor itself is situated between a PKS and an 
NRPS cluster.   This indicates that the compounds may be one of set of polyketides, short 








Figure 16.  Mass spectra of transcription factor overexpression strains overproducing identifiable compounds. The control strain 
is the vector transformant only (ANIp7) (A) NRRL3_00148 overexpression produces the azanigerones.  (B) NRRL3_09545 
overexpression produces BMS-192548/TAN-1612. (C) NRRL3_02186 overexpression increases production of fumonisins compared 
to controls. (D) NRRL3_00406 overexpression produces pyrophen. (E) NRRL3_11765 overexpression produces the tensyuic acids 
and other alkyl citric acids. (F) NRRL3_07873 overexpression produces malformin A. (G) NRRL3_08781 generates a set of unknown 
peaks.  The 214.0892 m/z observed in the positive spectra of the NRRL3_11765 overexpression and control strains correspond to the 











Among the transcription factors which generated identifiable (by mass spectrometry) 
compounds, our focus shifted to a single transcription factor (NRRL3_11765) where the mass 
spectrometry (MS) data revealed the presence the tensyuic acids (Figure 16E).  We selected 
these compounds for pathway reconstruction since, to our knowledge, they have no known 
genetic underpinnings and had been previously shown to possess useful biological properties 
[93, 94]. Three other alkyl citric acid masses corresponding to 2-carboxymethyl-3-hexylmaleic 
acid, its anhydride and hexylitaconic acid were also identified (Figure 16E).   
3.2.2 Overexpression of transcription factor NRRL3_11765: transcriptome analysis 
 
Examining the upregulated genes in the RNA-seq transcriptome of the NRRL3_11765 
overexpression strain (Table 7), we could determine which genes are likely involved in the 
biosynthesis of the alkyl citric acids.  Based on these expression we refined the previously 
annotated cluster which now included a gene of unknown function (NRRL3_11757) and 
excluded a transcription factor (NRRL3_11760), a zinc finger protein (NRRL3_11762) and a 
polyprenyl synthase (NRRL3_11768) (Figure 17).  The up-regulated genes in the cluster span 
from gene NRRL3_11757 to NRRL3_11769.  Based on the functional annotation of the up-
regulated genes within the cluster, we could only account for the production of the 2-
carboxymethyl-3-hexylmaleic acid compound.   We therefore assigned a cha (for 2-
carboxymethyl-3-hexylmaleic acid) identifier to the genes that are up-regulated in the 
NRRL3_11765 overexpression strain in this region. We therefore refer to the NRRL3_11765 
transcription factor as chaR, the overexpressing strain as chaR
OE
 and the parent strain as the 
control strain.  We also noted that another cluster containing genes (NRRL3_02448 – 
NRRL3_02450) with predicted functions to generate itaconic acid from citric acid [141] is 
down-regulated in chaR
OE
 (Table 8).   Itaconic acid was not detected in the extracellular growth 





Figure 17. Clustered genes upregulated (grey and black arrows) by chaR and clustered genes 
whose expression is unaffected (white arrows) by overexpression of chaR.  Labelled cha 
genes represent backbone (black arrows) and accessory enzymes (grey arrows) determined to be 




















Table 7. Genes up regulated in the chaR
OE
 strain compared to controls.  Highlighted portion 










p-value Predicted function 
NRRL3_11769 2.82 19.2 2.77 1.69E-05 Aldehyde dehydrogenase 
NRRL3_11767 0.06 36.1 9.23 8.94E-30 Fatty acid synthase subunit beta  
NRRL3_11766 0.06 82.98 10.43 1.72E-29 2-methylcitrate dehydratase 
NRRL3_11765 0.02 181.95 13.15 9.09E-41 Fungal specific transcription factor 
NRRL3_11764 0.01 1892.31 17.53 1.51E-55 Citrate synthase 
NRRL3_11763 0.09 1241.98 13.75 3.41E-53 Fatty-acid synthase 
NRRL3_11761 6.39 852.5 7.06 1.61E-24 MFS-type transporter 
NRRL3_11759 22.35 1547.48 6.11 6.85E-20 Dienelactone hydrolase family protein 
NRRL3_11758 2.19 23.51 3.42 1.71E-04 Fungal specific transcription factor 
NRRL3_11757 5.9 62.65 3.41 2.20E-07 Unknown function 
NRRL3_11501 2.15 17.03 2.99 2.14E-05 Amidohydrolase 2 family protein 
NRRL3_11500 88.84 1262.62 3.83 3.67E-11 Aldo/keto reductase family protein 
NRRL3_11100 3.53 23.39 2.73 3.00E-05 Short-chain dehydrogenase 
NRRL3_10103 16.72 687.64 5.36 4.98E-17 ATP-citrate synthase subunit 1 
NRRL3_10102 17.7 593.56 5.07 6.70E-16 ATP-citrate synthase subunit 
NRRL3_09843 2.19 51.75 4.56 1.05E-12 FAD-linked oxioreductase family protein 
NRRL3_09788 1.5 139.39 6.54 1.39E-18 Short-chain dehydrogenase 
NRRL3_09757 1.41 22.31 3.98 1.18E-08 Aldo/keto reductase family protein 
NRRL3_08741 2.51 15.45 2.62 3.65E-05 Unknown function 
NRRL3_08622 15.74 84.03 2.42 8.34E-06 Short-chain dehydrogenase 
NRRL3_08414 12.72 59.69 2.23 2.64E-05 Serine hydrolase FSH1 family protein 
NRRL3_08394 1.17 14.84 3.66 1.54E-06 Fungal specific transcription factor 
NRRL3_08390 4.09 24.57 2.59 8.50E-05 NmrA-like family protein 
NRRL3_08383 0 152.45 Inf 6.66E-37 O-methyltransferase family protein 
NRRL3_08061 19.2 93.78 2.29 2.07E-05 L-Serine ammonia-lyase 
NRRL3_07921 4.09 40.71 3.32 3.72E-06 Short-chain dehydrogenase 
NRRL3_07736 7.35 256.7 5.13 2.64E-15 Fungal specific transcription factor 
NRRL3_07496 2.33 34.4 3.88 7.29E-10 Transmembrane amino acid transporter protein 
NRRL3_07364 1.62 15.07 3.22 1.30E-06 MFS-type transporter 
NRRL3_07196 2.12 28.96 3.77 1.76E-09 Reverse transcriptase / Endonuclease 
NRRL3_07007 4.78 26.28 2.46 3.60E-05 C6-zinc finger domain-containing protein 
NRRL3_06970 8.42 90.73 3.43 3.51E-09 AMP-dependent synthetase 
NRRL3_06778 9.53 57.11 2.58 2.75E-05 3-oxoacyl-[acyl-carrier-protein] reductase 
NRRL3_06474 16.06 99.24 2.63 2.05E-06 Short-chain dehydrogenase 
NRRL3_06447 3 38.38 3.68 3.37E-09 Zinc-type alcohol dehydrogenase 
NRRL3_06436 1.02 63.29 5.96 4.87E-17 Beta-glucosidase 
NRRL3_06423 92.81 804.03 3.11 1.70E-08 Aldo/keto reductase family protein 
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NRRL3_06323 5.93 41.95 2.82 4.45E-06 Endonuclease III-like protein 
NRRL3_06281 0.97 17.51 4.17 1.48E-07 Zinc-type alcohol dehydrogenase 
NRRL3_06279 1.16 18.65 4.01 9.77E-09 MFS-type transporter 
NRRL3_06229 0.58 12.38 4.42 1.47E-09 Fungal specific transcription factor 
NRRL3_06131 21.24 131.9 2.63 2.80E-06 NADPH-adrenodoxin reductase, mitochondrial 
NRRL3_06061 0.44 23.53 5.74 5.59E-11 Unknown function 
NRRL3_05609 9.52 59.48 2.64 1.70E-05 NAD(P)-binding domain-containing protein 
NRRL3_05463 44.53 185.87 2.06 1.60E-04 GNS1/SUR4 membrane family protein 
NRRL3_05398 5.98 70.35 3.56 5.85E-08 Short-chain dehydrogenase 
NRRL3_04990 0.48 11.66 4.60 2.22E-08 Beta-glucosidase  
NRRL3_04324 4.94 54.14 3.45 3.94E-09 ABC-2 type transporter 
NRRL3_04323 5.55 99.76 4.17 4.82E-11 MFS-type transporter 
NRRL3_03973 1.85 69.79 5.24 3.01E-14 Disease resistance family protein 
NRRL3_03750 1.34 41.46 4.95 9.16E-12 FAD- domain protein/monooxygenase 
NRRL3_03531 43.04 179.24 2.06 8.20E-05 Cystathionine beta-synthase 
NRRL3_03431 61.4 452.81 2.88 2.84E-06 Acetyl-CoA carboxylase (ACC)  
NRRL3_03003 8.67 59.52 2.78 2.91E-06 Cytochrome P450 family protein 
NRRL3_02974 1.75 39.78 4.51 6.07E-10 Acyl-CoA desaturase 
NRRL3_02906 2.22 39.14 4.14 1.87E-09 NAD(P)-binding domain-containing protein 
NRRL3_02295 3 56.22 4.23 7.53E-10 Short-chain dehydrogenase 
NRRL3_02207 25.14 153.34 2.61 3.50E-06 Salicylate hydroxylase 
NRRL3_02206 5.49 35.93 2.71 3.99E-06 Hydantoinase B/oxoprolinase family protein 
NRRL3_02101 12.82 63.15 2.30 3.08E-05 Fungal specific transcription factor 
NRRL3_02100 4.76 115.48 4.60 1.05E-12 MFS-type transporter 
NRRL3_01768 59.17 497.8 3.07 3.32E-08 NAD dependent epimerase 
NRRL3_01429 1.77 15.98 3.17 8.17E-06 Short-chain dehydrogenase 
NRRL3_01224 12.1 52.92 2.13 8.14E-05 Carbohydrate-Binding Module Family 18  
NRRL3_01223 20.28 78.58 1.95 1.45E-04 Glycoside Hydrolase Family 55  
NRRL3_01212 8.35 60.4 2.85 6.10E-07 Carbohydrate-Binding Module Family 50 
NRRL3_01029 2.98 65.31 4.45 2.60E-10 Short-chain dehydrogenase 
NRRL3_00829 4.47 42.51 3.25 2.41E-07 Conserved unknown protein 
NRRL3_00745 2.66 242.79 6.51 3.77E-19 Unknown function 
NRRL3_00700 2.27 21.72 3.26 1.01E-05 Short-chain dehydrogenase 
NRRL3_00546 191.64 1145.5 2.58 3.62E-06 Mitochondrial citrate/oxoglutarate carrier protein 
NRRL3_00504 2.07 13.45 2.70 1.70E-04 Cis-aconitate decarboxylase 
NRRL3_00386 36.48 169 2.21 1.26E-05 MFS-type Sugar/inositol transporter 
NRRL3_00357 3.63 23.42 2.69 3.44E-05 Conserved unknown protein 
NRRL3_00308 4.19 81.05 4.27 1.86E-06 Unknown function 
*Inf = Infinite 




Table 8. Genes down-regulated in the chaR
OE
 strain compared to controls.  Highlighted portion 










p-value Predicted function 
NRRL3_11794 49.52 1.4 -3.25 2.24E-09 Conserved unknown protein 
NRRL3_11673 24.63 1.06 -2.86 3.56E-07 Basic-leucine zipper (bZIP) transcription factor 
NRRL3_11598 47.75 7.79 -1.65 1.60E-04 Amidase, hydantoinase 
NRRL3_11498 304.18 27.9 -2.17 1.02E-06 Cupin superfamily protein 
NRRL3_11493 31.46 2.87 -2.18 1.60E-05 Unknown function 
NRRL3_11028 182.51 26.6 -1.75 5.69E-05 SnoaL-like domain-containing protein 
NRRL3_10386 27.95 0.77 -3.27 6.03E-08 Unknown function 
NRRL3_10374 65.56 8.35 -1.88 9.33E-05 Zinc-type alcohol dehydrogenase 
NRRL3_10371 29.86 3.11 -2.06 1.78E-04 Serine hydrolase FSH1 family protein 
NRRL3_10369 66.51 7.31 -2.01 2.45E-05 Methyltransferase type 11 domain-containing protein 
NRRL3_10215 197.8 28.26 -1.77 1.39E-04 Heat shock protein 20 
NRRL3_10109 60.74 5.62 -2.17 1.38E-06 MFS-type transporter 
NRRL3_09550 131.31 1.05 -4.40 5.90E-21 MFS-type transporter 
NRRL3_09477 46.36 4.37 -2.15 1.52E-06 Cytochrome P450 family protein 
NRRL3_09010 101.68 14.55 -1.77 6.54E-05 Amidohydrolase family protein 
NRRL3_08986 33.71 2.58 -2.34 7.12E-06 Methyltransferase domain-containing protein 
NRRL3_08850 31.73 3.12 -2.11 1.70E-05 Amidase family protein 
NRRL3_08747 44.95 5.13 -1.98 7.41E-05 Heat shock protein 20 
NRRL3_08658 1556.54 239.27 -1.70 9.12E-05 Unknown function 
NRRL3_08340 135.51 1.2 -4.30 3.34E-13 Carboxymuconolactone decarboxylase family protein 
NRRL3_08288 97.09 5.48 -2.62 1.53E-09 AAA ATPase domain-containing protein 
NRRL3_07887 235.88 25.15 -2.04 2.58E-05 Unknown function 
NRRL3_07886 24.79 4.18 -1.62 1.42E-04 Tetratricopeptide-like helical domain-containing protein 
NRRL3_07772 40.23 5.22 -1.86 2.33E-05 Linoleate 8R-lipoxygenase 
NRRL3_07337 11.78 0.62 -2.68 2.50E-05 Unknown function 
NRRL3_06897 59.59 5.68 -2.14 6.65E-06 Cytochrome P450 family protein 
NRRL3_06872 25.22 5.05 -1.46 1.42E-04 Tetratricopeptide-like helical domain-containing protein 
NRRL3_06728 136.95 17.53 -1.87 3.69E-05 C2H2-like zinc finger domain-containing protein 
NRRL3_06394 223.43 18.58 -2.26 1.18E-06 EBP family protein 
NRRL3_06331 71.98 5.89 -2.28 1.17E-06 1-aminocyclopropane-1-carboxylate deaminase 
NRRL3_06275 41.31 2.04 -2.74 1.04E-10 Unknown function 
NRRL3_06189 46.8 6.75 -1.76 3.10E-05 Nonribosomal peptide synthetase-like enzyme 
NRRL3_05997 121.4 19.18 -1.68 8.57E-05 3-isopropylmalate dehydratase 
NRRL3_05625 14.37 0.96 -2.46 3.27E-07 Linoleate 10R-lipoxygenase 
NRRL3_05588 14.57 2.63 -1.56 4.74E-05 Hybrid PKS/NRPS 
NRRL3_05587 1052.45 106.59 -2.08 3.29E-06 EthD domain-containing protein 
NRRL3_05586 61.8 5.45 -2.21 6.36E-06 Zinc-type alcohol dehydrogenase 
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NRRL3_05464 19.84 0.08 -5.02 3.76E-06 Unknown function 
NRRL3_04967 45.12 3.9 -2.23 4.51E-05 Unknown function 
NRRL3_04660 308.04 14.58 -2.78 1.30E-10 Unknown function 
NRRL3_04562 16.84 2.21 -1.85 3.68E-05 HET domain-containing protein 
NRRL3_04536 14.83 0.84 -2.61 2.49E-06 Amidase 
NRRL3_04409 365.88 48.37 -1.84 2.55E-05 Glutathione S-transferase 
NRRL3_04122 287.64 24.5 -2.24 1.52E-07 NADH-cytochrome b5 reductase 
NRRL3_03871 168.99 2.25 -3.93 3.51E-13 Fungal hydrophobin family protein 
NRRL3_03740 22.64 1.45 -2.50 7.73E-06 Unknown function 
NRRL3_03591 168.78 12.09 -2.40 4.72E-07 Polysaccharide deacetylase 
NRRL3_03284 10.81 0.68 -2.52 1.23E-07 Transferase family protein 
NRRL3_03199 55.9 6.46 -1.96 2.24E-05 Metallo-dependent hydrolase  
NRRL3_03198 243.32 37.67 -1.70 1.38E-04 Guanyl-specific ribonuclease 
NRRL3_03130 200.84 23.89 -1.94 8.94E-06 Lactam utilization protein lamB 
NRRL3_02998 356.24 57.14 -1.67 1.33E-04 Nitrite transporter, high-affinity  
NRRL3_02996 95.28 7.43 -2.32 2.36E-07 GTP cyclohydrolase II family protein 
NRRL3_02994 40.22 3.64 -2.19 2.25E-05 Uracil phosphoribosyltransferase 
NRRL3_02986 178.86 22.14 -1.90 1.56E-05 Alpha/beta hydrolase fold domain-containing protein 
NRRL3_02951 11.17 0.74 -2.47 2.86E-06 MFS-type transporter 
NRRL3_02862 46.39 4.67 -2.09 2.28E-05 L-asparaginase 
NRRL3_02821 27.75 1.71 -2.54 5.32E-07 FAD-linked oxioreductase family protein 
NRRL3_02561 94.3 6.1 -2.49 1.27E-08 NADH:flavin oxidoreductase 
NRRL3_02560 399.35 22.49 -2.62 1.99E-09 NmrA-like family protein 
NRRL3_02557 218.09 18.01 -2.27 3.13E-07 Methionine aminopeptidase 1 
NRRL3_02534 40.8 2.21 -2.65 2.62E-08 NmrA-like family protein 
NRRL3_02450 33.78 1.25 -3.00 2.20E-09 Cis-aconitate decarboxylase 
NRRL3_02449 18.1 2.15 -1.94 1.31E-04 Citrate synthase 
NRRL3_02448 12.08 0.18 -3.83 2.11E-07 2-methylcitrate dehydratase 
NRRL3_01961 18.03 0.78 -2.86 1.38E-09 ABC transporter 
NRRL3_01724 153.1 4.51 -3.21 6.67E-12 Alpha/beta hydrolase fold domain-containing protein 
NRRL3_01672 46.37 3.67 -2.31 1.98E-06 FAD dependent oxidoreductase domain-containing protein 
NRRL3_01443 63.78 0.36 -4.71 7.30E-09 Unknown function 
NRRL3_01338 32.17 2.12 -2.48 3.63E-08 Calycin domain-containing protein 
NRRL3_01334 11.93 1.19 -2.10 2.34E-06 Non-Linear Nonribosomal peptide synthetase 
NRRL3_01127 64.17 5.72 -2.20 1.31E-06 Dihydroxyacetone kinase  
NRRL3_00992 16.3 0.1 -4.64 2.58E-10 Fatty acyl-CoA reductase 
NRRL3_00733 11.46 0.5 -2.85 1.99E-06 Fungal specific transcription factor 
NRRL3_00479 40 4.85 -1.92 1.94E-05 Sulfhydryl oxidase 
NRRL3_00287 468.88 14.52 -3.16 4.05E-11 Glutathione-dependent formaldehyde-activating family protein 
NRRL3_00247 16.63 0.53 -3.14 8.76E-07 Carbonic anhydrase 
NRRL3_00177 16.88 1.62 -2.13 1.08E-05 Carboxylesterase, type B family protein 
NRRL3_00095 13.82 1.43 -2.06 4.74E-05 Tetratricopeptide-like helical domain-containing protein 
NRRL3_00027 46.73 4.43 -2.14 1.63E-05 HAD-like hydrolase superfamily protein 
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3.2.3 Overexpression of transcription factor NRRL3_11765: Compound identification by nuclear 
magnetic resonance (NMR) 
 
We used NMR to elucidate the structures of compounds produced by the chaR
OE
 strain.  
The NMR analysis of isolated compounds from media extracts of the chaR
OE 
strain identified the 
structures of hexylitaconic acid, 2-carboxymethyl-3-hexylmaleic acid, hexylcitraconic acid, a 
hydroxylated form of hexylitaconic acid and a carbonylated form of hexylitaconic acid (Figure 
18, Table 9).   No structural solutions were obtained for the anhydride form of 2-carboxymethyl-
3-hexylmaleic acid, a compound that has previously been identified from A. niger [92], or any of 

















Figure 18. Structures elucidated from chaR
OE 

















Table 9. Chemical shifts and coupling constants for all elucidated structures isolated from 
chaR
OE 
media extracts.  Compound numbers correspond to structures in Figure 18. 
No. 






























1 165.093   179.571   166.253   175.709 
  178.495   
2 147.95   46.288 
3.485 (t)   
J2-5: 7.0 
144.755   46.561 
3.451 (t)            
J2-5: 7.0 
46.506   
3 135.596   136.909   140.415   139.428   137.075 
3.446 (t); 
J2-5: 7.5 

























































































































































3.2.4 Overexpression of transcription factor chaR: The tensyuic acids 
 
In both positive and negative MS modes, the chaR
OE
 strain exhibited peaks with masses 
corresponding to those of the four-hydrocarbon tail (C4) tensyuates A and F, the six-hydrocarbon 
tail (C6) tensyuates B-D, and the eight-hydrocarbon (C8) tensyuate E.  Moreover, the order of 
elution (F, A, B, C, D and E) of these acids, acknowledging the ambiguity of equal massed 
tensyuates A/F and C/D, appears consistent with that reported by Klitgaard, A., et al.  The 
Klitgaard,  A., et al study, like in our study, used a C18 column and a similar solvent gradient to  
ours [142].  To help visualize these peaks in isolation between chaR
OE
 and the control strain, we 
used extracted ion chromatograms (EIC) (Figure 19A-D).  One item of note was the absence of 
detectable C4 and C8 versions of hexylitaconic acid and 2-carboxymethyl-3-hexylmaleic acid 
above peak intensity threshold (5x10
4
) indicated either a potential preference for the production 
of the C6 tensyuate variates in A. niger NRRL3.  All EIC’s for putative compounds identified by 
mass spectrometry are shown in Figure 19.  The MS profile of the intracellular fraction showed a 
similar peak complement to that of the extracellular media.  Intracellular fractions did not have 
any unique identified peaks and were missing peaks with m/z ratios of 245.1017 (tensyuic acids 
A/F), 197.117 (hexylcitratconic acid) and 257.1017 (veridicatic acid) that were present in 
external fractions.  Peaks which were common to both fractions were ~2 orders of magnitude 














Figure 19.  Overlaid EICs of control (black) and chaR
OE
 (grey) strains.  All EICs are shown in 
positive mode excluding panel D in negative mode.  Numbers above peaks represent peaks 
above detection threshold; peaks below detection threshold are not numbered apart from panel C 




3.3 Alkyl citric acid pathway reconstruction in A. niger 
 
Combining MS, NMR and transcriptomic data, we reconstructed a biosynthetic pathway 
that included the tensyuic acids.  To fill in the gaps in the biosynthetic sequence for the 
production of 2-carboxymethyl-3-hexylmaleic acid and the tensyuic acids, I tried to anticipate 
the existence of intervening compounds. Adding the chemical formulas of predicted compounds 
to our database, I attempted to identify previously unidentifiable peaks in our MS spectrum data 
to gain supporting evidence for the compounds presence in growth media.  Starting with 2-
carboxymethyl-3-hexylmaleic acid, we anticipated the existence of a 2-hexylcitric acid precursor 
based on the up-regulation of cha6, the gene predicted to encode 2-methylcitrate dehydratase 
(Table 7).  A lactone ring anhydride form of 2-hexylcitric acid was also anticipated since a ring 
forms of other alkyl citrates had also been previously identified [92].  The presence of a ring 
opening dienelactone hydrolase (the up-regulated cha2, Table 7) also supported this prediction.  
Surveying our MS data with the chemical formulas for these two compounds, peaks with m/z 
ratios corresponding to 2-hexylcitric acid and its anhydride were identified in chaR
OE 
spectra 
(Figure 19A, F).   
For an explanation of 2-hexylcitric acid/anhydride biosynthesis, we attempted to 
distinguish whether the FAS is linking a completed fatty acid to a citric acid in the last iteration 
or if the FAS uses a citric-acid derivative as a starter unit.  Examining scenarios where citric acid 
is attached at the end or the beginning of the FAS chain elongation process failed to infer 2-
hexylcitric acid production due to the necessary loss of a carboxylic acid group in the form of 
CO2 from the citric acid moiety of 2-hexylcitrate in the condensation reaction [83, 143].  The 
loss of a carboxylic acid group from the fatty acid would result in a molecule with odd numbered 
hydrocarbon tail which was not detected in our MS spectrum data.  Attention shifted to the 
citrate synthase (Cha5) enzyme as a possible medium to carry out a condensation reaction.  
Analogous to the mechanism in citrate, 2-methylcitrate and 2-decylcitrate synthase enzymes 
[144, 145], I proposed that the clustered citrate synthase acts as the linking enzyme for 
oxaloacetate and fatty acid-CoA.  Supporting this idea, our expression data indicate a significant 
up-regulation of two citrate lyase subunit genes (NRRL3_10102, NRRL3_10103) whose enzyme 
product breaks down cytosolic citric acid to oxaloacetate and acetyl-CoA (Table 5) [146].  
During the experimental work for this thesis, a similar mechanism using a citrate synthase and 2-
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methylcitrate dehydratase enzyme was also proposed for the similarly structured hept/nonadride 
alkyl citrates by two other groups in the fungi Talaromyces stipitatus and Byssochlamys fulva 
[147, 148].   
For the biosynthesis of hexylitaconic acid, I proposed a decarboxylation of 2-
carboxymethyl-3-hexylmaleic acid; analogous to the itaconic acid pathway [141].  Reviewing 
our transcriptomic data (Table 7), I identified a non-clustered and significantly up-regulated cis-
aconitate decarboxylase gene (NRRL3_00504) which may be carrying out the decarboxylation 
reaction however, the clustered gene of unknown function (NRRL3_11757) cannot be ruled out 
as a candidate for this reaction. Alternatively, the recent work with the similarly structured 
hept/nonadrides suggested that the decarboxylation reaction may be occurring non-enzymatically 
via a “facile decarboxylation” [149].   
Focusing on the ring and open forms of the alkyl citrates, I surmised that the cha5 citrate 
synthase produces the ring anhydride forms of the alkyl citrates instead of the open forms for two 
reasons.  Firstly, the Cha2 enzyme facilitates the conversion of anhydride to acid forms and there 
does not appear to be any upregulated genes in our expression data which could produce 
enzymes to facilitate the reverse reaction.  Secondly, spontaneous condensation reactions of 
carboxylic acid converting dicarboxylate molecules to closed anhydride forms do not occur to 
the best of our knowledge [150].   It is currently unclear if the subsequent reactions converting 2-
hexylcitric acid/anhydride to the tensyuates take place in the open, closed or both forms. Figure 





Figure 20. A proposed biosynthetic pathway for hexylitaconic acid (A) and its conversion 
into the tensyuic acids (B).  Shaded boxes represent compounds identified by both MS and 
NMR.  All non-shaded compounds, apart from compounds 2a, 2b and 3, (inferred by enzymatic 
actions of FAS and citrate lyase enzymes) were identified by MS only. 
 
The lack of enzymes in the cha cluster to carry out tensyuate biosynthesis suggested that 
non-clustered enzymes might be involved; like we observed with the up-regulated and non-
clustered citrate lyase genes.  The transcriptomic data revealed a single significantly up-regulated 
o-methyltransferase (NRRL3_08383, only expressed in chaR
OE
 strain) which may be carrying 
out the o-methylations/o-ethylations (o-(m)ethylations) generating the tensyuates.  As for the 
carboxylate tail, the hydroxylated and carbonylated forms of hexylitaconic acid found in our 
NMR and MS analysis as well as the clustered aldehyde dehydrogenase (cha8) provided 
potential clues.  I surmised that a ω-oxidation reaction might be taking place on the terminal end 
of the hexylitaconic acid hydrocarbon tail.  A key piece of evidence was clustered aldehyde 
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dehydrogenase which facilitates the terminal enzymatic step in the ω-oxidation reaction.  
Additionally, the ω-oxidation reaction includes a P450 monooxygenase generating a 
hydroxylated hydrocarbon tail [148] and an alcohol dehydrogenase generating a carbonylated 
hydrocarbon tail [151].  This pathway has also been previously characterized in filamentous 
fungi with other fatty acid compounds [152].  Transcriptomic data showed two monooxygenases 
(NRRL3_03003, NRRL3_03750) that were significantly upregulated in the chaR
OE
 strain (Table 
7).  For the dehydrogenation portion of the ω-oxidation reaction, twelve zinc-type alcohol and 
short chain dehydrogenase candidates are significantly upregulated one or more of which may be 
contributing to the ω-oxidation reaction (Table 7).   Figure 20B shows a proposed pathway 
converting hexylitaconic acid to the tensyuates.   Lastly, we detected a number of peaks with m/z 
ratios corresponding to viridicatic acid; a compound nearly identical to 2-carboxymethyl-3-
hexylmaleic anhydride possessing an additional keto group near the aconitate head.  The other 
peaks may indicate alternate locations of the keto group including at the terminal end of the 
hydrocarbon tail potentially as part of a ω-oxidation reaction of 2-carboxymethyl-3-hexylmaleic 
anhydride.    
3.4 Supporting the reconstructed pathway by gene deletion: Using the reconstructed alkyl citric 
acid pathway to predict the metabolic outcomes from gene deletions 
 
To test the predictive power of our reconstructed pathway we designed three deletion 
cassettes for three genes in our pathway.  We selected first the clustered cha6 gene for deletion to 
lend support for the existence of our predicted 2-hexylcitric acid/anhydride and potentially obtain 
a structural solution by NMR.  Attributing the inability to detect 2-hexylcitric acid/anhydride to a 
lack of sufficient material, we anticipated that a cha6 deletion strain (∆cha6:chaROE) would 
achieve 2-hexylcitric acid/anhydride accumulation and allow for a structural determination of 
these compounds by NMR. I also anticipated the elimination of compounds downstream of 2-
hexylcitric acid/anhydride in the pathway.   
The ∆cha6::chaROE strain yielded an increased peak area corresponding to the mass of 2-
hexylcitric acid with a log2 fold change of 2.982 ± 0.15 (p-value < 0.01) and an increased peak 
area corresponding to the mass of 2-hexylcitric anhydride with a log2 fold change  of 3.792 ± 
0.26 (p-value < 0.01). All downstream compounds including the tensyuate m/z peaks were not 
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detected in MS data (Figure 21A-D).  Analyzing media extracts of our ∆cha6::chaROE by NMR 
we were able to verify the structures of 2-hexylcitric acid and 2-hexylcitric anhydride (Table 10, 









Figure 21.  Mass spectra of chaR
OE
 strain (A).  Mass spectra of ∆cha6:chaROE (B).  Overlaid EICs from the chaROE (dark gray), 
∆cha6:chaROE (light gray) and control strains (black but too low for visibility) for 2-hexylcitric acid in positive mode (C), 2-
hexylcitric anhydride in positive mode (D). The 2-hexylcitric anhydride compound appears to correspond to peak 1 in panel D.
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Table 10. Chemical shifts and coupling constants for 2-hexylcitric acid and 2-hexylcitric 
anhydride structures isolated from ∆cha6::chaROE media extracts.   
 
No. 
Chemical shifts (ppm), coupling constants (Hz), and COSY correlation 
2-hexylcitric acid 2-hexylcitric anhydride 
13C  1H  COSY 13C  1H  COSY 
1 DMSO
* 
1a: 2.898 (d); 1b: 
2.504 (d); J1a-1b: 
16.0 
H1a-H1b    




J3-4a: 14 ; J3-4b: 1.0 
H3-H4a-
H4b 
75.458   
4 31.460 4a: 2.377 (m); 
4b: 1.651 (m) 
H4a-H4b-
H5 
54.081 2.4025 (m) H4-H6a-H6b 
5 27.112 1.444 (m) H5-H4-H6 175.215   
6 29.032 1.226 (m) H6-H5-H7 26.923 6a: 1.651 (m),  
6b: 1.393 (m) 
H6a-H6b-
H7a-H7b 
7 31.582 1.226 (m) H7-H6-H8 27.750 7a: 1.226 (m),  
7b: 1.137 (m) 
H7a-H7b-
H6a-H6b-H8 
8 21.208 1.118 (m) H8-H9-H7 28.941 1.226 (m) H8-H7a-H7b-
H9 
9 14.531 0.842 (t) J9-8: 7.0 H9-H8 31.460 1.226 (m) H9-H8-H10 
10 174.18
3 
  22.423 1.226 (m) H10-H11-H9 
11 174.33
4 






  41.227 12a: 2.898 (d); 
12b: 2.504 (d); 
J12a-12b: 16.0 
H12a-H12b 
13    171.974   




Figure 22.  Structures elucidated from ∆cha6::chaROE  media extracts.   
 
Two additional cassettes were constructed to test the ω-oxidation and o-(m)ethylation 
aspects of the reconstructed pathway.  I selected the NRRL3_03750 as a deletion target to test ω-
oxidation since the log2 fold change in expression for NRRL3_03750 was higher than for 
NRRL3_03003 (4.95 ± 0.15 vs 2.78 ± 0.02).  The o-methyltransferase NRRL3_08383 was 
selected to test o-(m)ethylation in the pathway as the only candidate for that reaction.  Based on 
our pathway reconstruction, we predicted that a ∆NRRL3_03750::chaROE strain should terminate 
production at step 6 (Figure 20B) while a ∆NRRL3_08383::chaROE strain would terminate 
production before the tensyuic acids at step 8 and potentially generate enough material for NMR 
structural resolution of the carboxylated hexylitaconic acid at that step.   
The MS profile of the ∆NRRL3_03750::chaROE strain showed no apparent difference in 
identified peaks when compared to the MS profile of chaR
OE
.  Based on these data 
NRRL3_03750 does not appear to be involved in alkyl citric acid production.  A deletion 
cassette was also constructed for the o-methyltransferase NRRL3_08383 however the 
∆NRRL3_08383::chaROE strain could not be found despite extensive mutant screening.  
3.5 Citric acid levels in control, chaR
OE
 and ∆cha6:chaROE 
 To support our premise that citric acid is the primary molecule used for alkyl citric acid 
production, we measured the relative fold change of citric acid in control, chaR
OE
 and 
∆cha6::chaROE strains.  We predicted that both the chaROE and ∆cha6::chaROE strains would 
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require a greater pool of citric acid than the control strain in order to sustain both alkyl citric acid 
production and primary metabolism from the citric acid cycle.  We also noted that the chaR 
transcription factor contains a mitochondrial sequence tag indicating that it may also be involved 
in the regulation of the citric acid cycle.  The fold change in citric acid levels was determined by 
peak area from MS data.  We observed a significant increase of citric acid in the chaR
OE
 (log2 
fold change = 5.36 ± 0.81, p-value < 0.01) and ∆cha6::chaROE (log2 fold change = 3.96 ± 0.77, p-
value < 0.01) strains compared to the control strain.  Furthermore, the level of citric acid in the 
chaR
OE 
strain was significantly higher than in the ∆cha6:chaROE strain (log2 fold change = 1.41 ± 
















4.1 Secondary metabolism genes and gene clusters in A. niger NRRL3 genome 
4.1.1 Backbone enzymes in the genomes of A. nidulans, A. oryzae, A. fumigatus and A. niger. 
 
Differences in the distribution of SM enzyme types found in A. nidulans, A. oryzae, A. 
fumigatus and A. niger indicate that in addition to evolutionary relatedness, determination of the 
complement of SM genes in Aspergillus species may be subject to both horizontal gene transfer 
and gene cluster loss. We observed in the case of the four Aspergillus species under study that 
the distribution of SM enzyme types in A. nidulans appears to be more similar to that of A. niger 
and A. oryzae than that of the more closely related A. fumigatus [152].  The A. fumigatus genome 
also appears to have comparatively very few SM backbone enzymes compared to the other 
Aspergilli suggesting substantial SM gene cluster loss during its evolution.  While a phylogenetic 
and sequence analysis of the backbone enzymes in the studied Aspergilli was not performed to 
see which SM enzymes are shared between them, the number and category distribution 
differences of these enzymes might be explained by both horizontal gene transfer and 
gene/cluster loss.  Horizontal gene transfer of SM clusters has been previously inferred in 
filamentous fungi in the phylogenetic distributions of the sterigmatocystin and fumonisin clusters 
[152, 153].   
An additional line of evidence for the dynamic nature of SM clusters comes from our A. 
niger species comparison.  The results of this analysis showed, as in previous studies, that strains 
of the same species can lose or gain not just backbone enzymes but entire SM clusters (Figure 
16) [75].   In some cases a remnant backbone “gene” potentially indicates where an SM cluster 
had left the genome.  
4.1.2 Remnant cluster analysis 
 
The BLASTP method using the query sequences of contiguous SM domains to search for 
backbone enzymes in A. niger NRRL3, helped locate remnant backbone genes (in addition to the 
ochratoxin PKS remnant) in both the A. niger NRRL3 and CBS 513.88 genomes.  One aspect of 
this search revealed that it is mainly the highly reducing PKS backbone class that tend to leave 
behind a gene remnant.  To our knowledge, the reason and mechanism behind this observation is 
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currently unknown but a potential clue may lie in the evolutionary relatedness of highly reducing 
PKS enzymes with fungal FAS backbone genes.  Both FAS and PKS enzymes are currently 
thought to have a common point of origin given the similarities in their domain structure and 
metabolic products [154].  The tendency of highly reducing PKS enzymes to leave behind a 
portion of their 3’ end sequence may be an indication of their evolutionary origins from a 
progenitor it shared in common with fungal FASs.  A typical fungal FAS exists as a heterodimer 
wherein the alpha subunit contains an ACP domain followed by KR and the beta subunit 
containing AT and ER domains [153].  The tendency for PKS-like remnants to retain the ACP, 
and in some cases the KR domain, but not AT and rarely ER (An01g02030) domains may point 
to an FAS-like enzyme subunit fusion event in the past that later evolved into the highly reducing 
PKSs.  Further analysis and testing of these remnants from within other genomes are required to 
obtain a more extensive list of PKS-like enzymes to support our limited findings.    
Using protein sequences with only single SM domains as a subsequent BLASTP remnant 
search, no additional remnant genes were found. The vast majority (89 of 114) of single domain 
proteins observed in the NRRL3 genome were the PKS ER and KR domains.  Moreover, only 
one instance of a PKS-KS and PKS-AT domain were observed and no instances of genes 
containing a single PKS-DH could be found.  The significance of this observation is currently 
unclear however I speculate that these single domains are modified over time from remnants 
since nearly all of the single domain proteins sequences I could find appear in the 3’ end of 
highly or partially reducing PKSs like the remnants. These proteins may have been adapted for 
other novel functions or potentially as tailoring enzymes in other SM clusters.  A more extensive 
search through other fungal genomes may provide support for this hypothesis. 
Lastly, the PKS-like remnants appeared in two contexts within the genome.  Either only 
the backbone enzyme was missing or surrounding clustered genes and the backbone gene were 
missing.  It is unclear why these two types of cluster loss occur. A detailed study search for 
common sequence markers from within intact clusters and surrounding a homologous remnant 
may provide insight as to a possible mechanism of SM cluster loss by revealing the proteins 




4.1.4 The azanigerone and unknown FAS split cluster 
 
The position of the azanigerone cluster within the genome is one of the puzzling aspects 
of our cluster analysis.  To our knowledge, there is no observed instance of SM clusters 
appearing within other separate SM clusters.  It is currently unclear if the azanigerone cluster 
inserted itself within the FAS cluster or if the FAS cluster has split and inserted at either end of 
the azanigerone cluster.  A phylogenetic analysis of both clusters in related species may help sort 
out which scenario is correct.  If most related species possess the azanigerone cluster alone it is 
more likely that the FAS cluster inserted around it.  Conversely if most related species have the 
FAS cluster alone it is likely that the aznigerone cluster inserted into the FAS cluster. This 
unique organization may also present an insight into the horizontal gene transfer of SM clusters.   
By analyzing the sequences of these split clusters, DNA sequence markers could be revealed 
which may serve to identify mechanisms for SM cluster insertions (as opposed to the deletions 
outlined in the preceding section) into fungal genomes.   
4.1.5 Backbone definition in A. niger NRRL3 genome 
 
A comparison of the clusters defined in A. niger NRRL3 to CBS 513.88 revealed both 
strains share a nearly identical set of SM clusters.  However, like in previous A. niger strain 
comparisons [75], we also observed some differences in the composition of some clusters.  
Cluster differences between A. niger NRRL3 and CBS 513.88, as well as between other 
Aspergilli, appeared to take four forms: 1) completely missing clusters, 2) rearranged or 
dispersed clusters, 3) clusters with absent tailoring enzymes, and 4) truncated/remnant backbone 
genes.  Differences corresponding to tailoring gene complement within clusters or cluster 
rearrangements appear to have only minor effects on SM production in some cases.    The 
fumonisin cluster of A. niger has only 11 of the 17 genes reported in Fusarium species but can 
still produce fumonisins B2 and B4 [153].  Additionally, the scattered pigmentation cluster  in A. 
niger still generates DHN melanin and its pigment derivatives despite its extensive 
rearrangement in the genome [103].    In cases where a backbone enzyme is missing, 
metabolomics changes can be much more profound.  For example, the inability to produce 
ochratoxin by strain NRRL3, as compared to strain CBS 513.88 [113] can be explained by 
partial loss of the ochratoxin PKS gene since the core molecule can no longer be made.   
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4.2 Overexpression of defined clusters 
4.2.1 Transcription factor overexpression induces the production of SMs from their parent 
clusters in only a few cases 
 
By overexpressing the regulators of defined clusters, we sought to determine their 
metabolic products.  In the majority of cases, MS data from strains overexpressing clustered 
transcription factors (28 of 35) were similar to the spectra from the non-expressing controls 
indicating a lack of expression from cryptic clusters.  The reason for the lack of cluster activation 
by clustered transcription factor overexpression is unclear. I submit however, four potential 
explanations that may serve as considerations in similar experiments in the future.  First, given 
the random integration of our overexpression vectors, the observed difficulties in cluster 
expression might be linked to vector insertion into transcriptionally silent or poorly expressing 
areas of the genome. Similarly, insertion in areas of high expression may cause a negative 
feedback and shut down production of the transcription factor.  A targeted insertion of 
transcription factor overexpression vectors into moderately transcriptionally active areas may 
solve this problem.  Second, some mechanism of repression may be involved in the regulation of 
SM clusters.  The relatively low expression level of chaR despite being under the control of a 
strong promoter could indicate that A. niger may have countermeasures in place to reduce SM 
transcription factor transcript/protein levels or to inhibit their function.   Deletion of these 
inhibitory mechanisms, once identified, may facilitate SM biosynthesis from target clusters.  
Third, clustered transcription factors may only regulate a small number of SM clusters and the 
majority may be regulated by transacting transcription factors from elsewhere in the genome or 
by global regulators like the LaeA which regulates 20-40% of SM genes in A. fumigatus [109].  
Global repressors of secondary metabolism may also be considered.  Lastly, epigenetic factors 
can also influence the expression of SM clusters [110].  Reducing epigenetic gene silencing 
mechanisms may then induce expression either on its own or by subsequent expression of 





4.2.2 Transcription factor induced SM production reveals the putative genetic underpinnings of 
orphan compounds 
 
From the transcription factors that appeared to induce SM production, we detected the 
overproduction of three identifiable orphan compounds.  These were pyrophen, the alkyl citric 
acids and the malformins. The gene clusters associated with pyrophen and the tensyuic acids 
appear to have enzymatic functions that coincide with the chemical structures for these 
compounds.  In the case of the putative pyrophen cluster NRRL3_00410 (transcription factor 
NRRL3_00406), a tyrosinase/chatechol oxidase and an NRPS-like gene provide ready 
explanations for the incorporation of a benzyl group linked to a nitrogen atom from an aromatic 
amino acid like tyrosine or phenylalanine (Figure 9, Table 4).  Looking at the alkyl citric acids, 
the FAS and citrate producing/modifying enzymes in the NRRL3_11765 cluster appeared to 
explain the fatty acid and citrate derived components of the tensyuic acid compounds [93].  In 
the case of the malformins however, the biosynthetic mechanism could not be worked out based 
on the cluster in the vicinity of the transcription factor. 
Overexpression of NRRL3_07881 transcription factor resulted in the over-production of 
malformins. However, the SM gene cluster encompassing the NRRL3_07881 transcription factor 
does not show any corresponding backbone or tailoring enzymes explaining its biosynthesis. The 
malformins are cyclic pentapeptides containing a disulfide bridge between two cysteine residues 
(Figure 9).  The main backbone enzyme in the NRRL3_07881 cluster is a partially reducing PKS 
(NRRL3_07884) which does not generate peptides according to current understanding [50, 67, 
71].  An NRPS-like enzyme (NRRL3_07881) is also present but it contains only a single A 
domain.  Since the current understanding of NRPS peptide assembly proposes that each A 
domain can recognize only one amino or hydroxyl acid and because malformins comprise four 
different amino acids (L-isoleucine, two D-cysteines, L-valine, and D-leucine), the minimum 
number of A domains for a malformin producing NPRS should be four [155].  Moreover, given 
that both D-amino acids are incorporated along with L-amino acids, ribosomal production of the 
malformins is also unlikely given that protein biosynthesis only incorporates L-amino acids and 
does not cause peptide cyclization.  Considering these constraints, NRRL3_07881 may be 
regulating malformin production from a distantly located cluster.  A review of the annotated 
clusters revealed that, an NRPS cluster containing the NRPS backbone NRRL3_08969 is a likely 
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candidate.  The NRPS backbone contains four A domains as predicted as well as a disulfide 
modifying enzyme (NRRL3_08968) which could account for the disulfide bridge between 
malformin’s two cysteine residues (Figure 9B) [156].  Proteomic analysis (data not shown) of 
our malformin producing strain was inconclusive as no backbone enzymes were found to be up 
regulated.  A transcriptomic profile may provide a more definitive answer. 
4.3 Alkyl citric acid pathway reconstruction in A. niger 
4.3.1 Low production of some metabolites may preclude their structural elucidation by NMR. 
 
The pathway reconstructed by NMR, MS and transcriptome data provided insights into 
the biosynthesis of the alkyl citric acids.  However, some of the proposed precursors and 
terminal products could not be identified by NMR.  We attributed our inability to obtain 
structural solutions for these compounds to a lack of sufficient material.  Looking at 2-
carboxymethyl-3-hexylmaleic anhydride, the lack of sufficient material may be due in part to the 
ring opening action of the cha2 gene (log2 fold change = 6.11 ± 0.90) skewing the state of this 
compound to an open acid form.  As for the tensyuic acids and the tail carboxylated 
hexylitaconic acid, the lack of sufficient material seemed less obvious.  The cha cluster lacked 
all enzymes, save cha8 (log2 fold change = 2.77 ± 0.36), to carboxylate the hexylitaconic acid 
tail by ω-oxidation.  However, the low expression levels of the gene cha8, the gene of unknown 
function (which may also be involved in ω-oxidation) (log2 fold change = 3.41 ± 0.23) and the 
non-clustered cis aconitate decarboxylase NRRL3_00504 (log2 fold change = 2.70 ± 0.02) may 
point to a low frequency of ω-oxidation and subsequent decarboxylation due low enzyme 
production.  Based on our pathway, this could then lead to a low concentration of tensyuic acids.  
It is also worth pointing out that some of the compounds which could not be identified by 
NMR had MS peak areas comparable to or higher than some of those which could be elucidated 
by NMR (Figure 19).  For instance, peak areas corresponding to tensyuic acids C and D (Figure 
19B) that could not be identified by NMR were ~10 fold higher than that of hexylitaconic acid 
(Figure 19E)  which could be identified by NMR.  This discrepancy may be due to ionization 
differences between these compounds; those which ionize better may produce higher peaks 
despite having low concentrations since more of its ions hit the MS detector.   
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4.3.2 Strategies for the detection of the tensyuic acids 
 
Currently the only support this study has been able to show for the production of the 
tensyuates by chaR overexpression is the detection of peaks with m/z ratios corresponding to the 
tensyuic acids in MS data and the order of their elution on a C18 column.  If a lack of sufficient 
material is responsible for our inability to detect the tensyuates by NMR, increasing tensyuate 
concentration may help.  To achieve this, we propose two ways of increasing tensyuate 
concentration.  The first method involves the overexpression of the decarboxylating enzyme(s) 
generating increased hexylitaconic acid or the enzymes putatively involved in ω-oxidation (like 
cha8).  A second method is to simply grow greater volumes of stationary culture to isolate 
enough material.   
4.3.3 Citric acid feeds the alkyl citric acid pathway 
Based on the upregulated citrate lyase subunits which break down citric acid [146] and 
the action of the Cha5 citrate synthase, citric acid appears to be the primary building block 
feeding the alkyl citric acid biosynthetic pathway.  Assays to quantify citric acid by MS analysis 
also showed that transcription factor induced expression of this pathway appears to have a 
corresponding increase in the concentration of extracellular citric acid.  In the case of the 
∆cha6:chaROE, we observed that while the relative concentration of citric acid was significantly 
higher than the control strain, it was significantly lower than the chaR
OE
 strain.  The reason for 
this difference is unclear however, I speculate that the significant increase of 2-hexylcitric 
acid/anhydride may be causing a negative feedback loop through some as yet unknown 
mechanism which is either reducing citric acid production, reducing the transport of citric acid to 
the cytosol or shunting the breakdown products (oxaloacetic acid and acetyl-CoA) of citric acid 
into other pathways. 
A key feature in this early part of the alkyl citric acid pathway appears to be a highly 
upregulated mitochondrial citrate/oxoglutarate carrier protein (NRRL3_00546, log2 fold change 
= 2.58 ± 0.23) (Table 7). In Saccharomyces cerevisiae, the orthologous mitochondrial transporter 
functions as a citric acid shuttle (by oxoglutarate exchange) from the mitochondrion to the 
cytosol in order to increase the redox state of cytosolic NADPH (Figure 23) [157].  The specific 
role of this antiporter in the reconstructed alkyl citric acid pathway is unknown as the enzymes 
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converting citrate to isocitrate (Aco1p) and isocitate to oxoglutarate (Idp2p) do not appear to 
have a corresponding upregulation in the genome following chaR overexpression.  However, I 
anticipate that the NRRL3_00546 up-regulation may be a response to increase the shuttling of 
citric acid from the mitochondria to the cytosol in order to feed the alkyl citrate pathway, 
generate NADPH required for fatty acid biosynthesis [158] or both.  Lastly, the chaR 
transcription factor appears to contain a mitochondrial localization sequence indicating a 
potential role in gene regulation in the mitochondria.  Green fluorescence protein fusion with 
chaR may help confirm its localization following translation.   
 
Figure 23.  Schematic of mitochondrial citrate/oxoglutarate carrier protein (Yhm2p) function in 
S. cerevisiae.  Taken from Castegna, A., et al. [157] 
 
 The observed significant downregulation of what appears to be an itaconic acid pathway 
in the chaR strain is also noteworthy.  Since this pathway facilitates the conversion of citrate to 
aconitate to itaconate [141] it appears that A. niger may be downregulating this pathway to focus 
citrate flux to the alkylcitrate pathway.  If this assessment is correct, deletion of the cha cluster 
may generate cytosolic citric acid and other small molecules (acetyl-CoA and oxaloacetate) with 
lower diversion to other pathways.  A strain overproducing these small molecular building 
blocks could be used to make a variety of endogenous and non-native SMs; particularly fatty 
acid and polyketides which require acetyl-CoA and malonyl-CoA for biosynthesis.  Moreover, 
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the upregulated acetyl-CoA carboxylase gene NRRL3_03431 (Log2 fold change = 2.88 ± 0.57) 
(Table 7.) may be facilitating increased production of malonyl-CoA [159].   
4.4 Testing the reconstructed pathway by gene deletion 
4.4.1 The mechanism of 2-hexylcitric acid and 2-carboxymethyl-3-hexylmaleic acid biosynthesis 
is similar to that of the heptadride/nonadrides 
 
Our reconstructed pathway successfully predicted the metabolic outcome of a cha6 
deletion and allowed for the structural elucidation of 2-hexylcitric acid/anhydride by NMR.  
During the preparation of this thesis, the citrate synthase/2-methylcitrate dehydratase 
reconstructed mechanism for 2-hexylcitric acid and 2-carboxymethyl-3-hexylmaleic acid 
biosynthesis was proposed by two other groups for the production of the hept/nonadrides in T. 
stipitatus and B. fulva [147, 149].  A notable difference between our alkyl citric acid pathway 
and the hept/nonadride pathway is in the production of the hydrocarbon tails.  In the 
hept/nonadride pathway the tail is generated by a highly reducing PKS rather than a FAS [147]. 
While the full gene cluster of the hept/nonadrides does not appear to be experimentally defined 
in T. stipitatus or B. fulva, these clusters appear to lack dienelactone hydrolase [147, 148].  This 
may indicate a preference for the ringed anhydride forms (the authors only show the ringed 
forms) for these species while in A. niger, the similarly structured alkyl citric acids appear in 
both the acid and anhydride forms.  There is currently no indication that tail carboxylation takes 
place for the hept/nonadrides. 
4.4.2 Deletion of non-clustered genes predicted to be involved in ω-oxidation and o-
(m)ethylation had no effect on alkyl citric acid production 
 
We intended to demonstrate direct involvement of non-clustered genes in the 
biosynthesis of alkyl citric acid SMs by deletion of significantly upregulated monooxygenase 
and o-methyltransferase genes.  In the case of the NRRL3_08383 o-methyltransferase gene, a 
deletion strain could not be obtained despite extensive screening of transformants.  Additional 
attempts at obtaining a deletion mutant need to be carried out to support the o-(m)ethylation 
aspect of the reconstructed pathway.   
101 
 
Support for the ω-oxidation of hexylitaconic acid portion of the pathway is provided by 
the structural elucidations by NMR and m/z peaks in MS data of two of the three compounds in 
this reaction; the fatty alcohol and fatty aldehyde forms of hexylitaconic acid.  Support for the 
hexylitaconic acid with a carboxylated tail is shown in the mass spectrum of chaR
OE 
media 
extracts (Figure 19C).  The predicted accumulation of hexylitaconic acid through the deletion of 
the NRRL3_03750 monooxygenase failed to affect a change in biosynthesis however, the list of 
potential monooxygenases has not been exhausted.  The significantly upregulated P450 
monooxygenase NRRL3_03003 is another prospective candidate but the list of potential 
candidates may not be limited to only those genes which are upregulated by chaR upregulation.  
Aspergillus niger may be using ω-oxidation P450 monooxygenases and other enzymes which are 
not affected by chaR overexpression but which are already highly expressed.   
Conclusions and future directions 
 
Using the domain doublet BLAST search method, we have outlined a robust method in 
identifying backbone enzymes in fungal genomes.  While additional testing in other genomes is 
required, this method may lend itself to automation by coding its rules into search algorithms.  
As for the clusters in which the backbones reside, SMURF and antiSMASH predictions appear 
to overlap well with experimentally verified clusters.  One issue with these algorithms is that 
they generate clusters that are contiguous.  This condition does not hold in many cases as 
evidenced by the many experimentally verified non-contiguous clusters.  This results in cluster 
predictions which do not account for potential cluster discontinuity like that observed in the 
pyranonigrin E carlosic acid, and alkyl citric acid clusters [47, 99].   Additionally, the tendency 
of SMURF and antiSMASH to overestimate the size of clusters currently necessitates inclustion 
of manual curation in cluster definition and suggests a need for additional training sets.  Ideally, 
the incorporation of other data sources in these algorithms, such as genome wide expression data, 
may aid in cluster definition by identifying differences in expression between genes in and 
outside of clusters.  For example, an SM cluster annotated with three P450 monooxygenases may 
be refined to included just one if two of those genes are highly expressed while the one closest to 
the backbone is very poorly expressed like the rest of the cluster.    
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I have used the pathway I reconstructed from MS data for 2-carboxymethyl-3-
hexylmaleic acid, hexylitaconic acid and their downstream products I was able to predict the 
metabolic outcome of a 2-methylcitrate dehydratase deletion.  Based on my results, the process 
of pathway reconstruction I demonstrate in this study can potentially serve as a predictive aid to 
overproduce specific and potentially novel compounds for structural elucidation and bioactivity 
assays. An incipient pathway can also be useful in targeted deletions where the end goal is to 
increase the concentration of particular compounds.   
Not all proposed compounds based on the masses observed in our MS data could be 
identified in NMR and therefore still cast doubt on some portions of the reconstructed pathway; 
namely the full ω-oxidation reaction as well as the o-(m)ethyl transfer reactions producing the 
tensyuic acids.  Alternative approaches to increase their bulk in media extracts may aid in 
pathway validation.  Going forward, a project to validate our proposed pathway will be required.  
This would include a systematic disruption of all clustered and non-clustered genes putatively 
involved in biosynthesis.  The construction of strains overexpressing other genes in the alkyl 
citrate cluster could also be useful for NMR structural elucidation of compounds at low 
concentrations.  Genes putatively involved in ω-oxidation and o-(m)ethylation would be prime 
candidates to overproduce carboxylated hexylitaconic acid and the tensyuic acids. 
Also planned are strain constructions containing multiple gene deletions to generate citric 
acid through the disruption of the clustered cha5 citrate synthase gene as well as the non-
clustered citrate lyase subunit.  Strains overproducing oxaloacetic acid and acetyl-CoA could 
also be developed by targeted deletion of the clustered FAS and cha5 genes.  Further afield, the 
introduction of enzymes from other pathways or non-native enzymes is planned to generate 
metabolites not known to be produced in A. niger or perhaps any other fungal species. The 
potential to produce itaconic acid, an industrial monomer used for producing plastics [160], may 
also be possible.   Currently this monomer is produced industrially in A. terreus at concentrations 
of 80 g/L.  Given that some acid producing strains of A. niger are capable of producing 200 g/L 
of citrate, an itaconate precursor, the potential exists to produce a strain of A. niger with 
theoretical yields of itaconate reaching 135 g/L.  A key reason why this could be viable is due to 
the increased availability of citric acid in the cytosol for conversion to itaconate.  This is one of 
the obstacles that need to be overcome in order to produce high titres of itaconate in A. niger.  
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Itaconate could then potentially be produced through the introduction of a citrate dehydratase 
and cis aconitate decarboxylase  from A. terreus or by upregulation of what appears to be an A. 
niger native itaconate pathway (NRRL3_02448 – NRRL3_02450) to carry out the citrate to 
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